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ABSTRACT
Post-transcriptional regulation of RpoS and HemA in Salmonella
Amy Madeline Jones
The first part of this thesis is dedicated to translational regulation of rpoS mRNA by the small
noncoding RNAs (sRNAs), DsrA and RprA, in two closely related enteric bacteria, Escherichia coli, and
Salmonella enterica serovar Typhimurium. The rpoS gene encodes a second vegetative sigma factor for
RNA polymerase, which directs the cell’s transcriptional response to general stress and entry into
stationary phase. The rpoS gene is highly conserved among the γ−branch of proteobacteria, and sRNAs
are highly conserved in related species. In fact, sequence conservation is thought to have predictive value
in sRNA discovery and functional conservation is largely assumed. First discovered in E. coli, DsrA and
RprA were shown to activate rpoS translation in response to low temperature and osmotic shock
respectively. Base pairing between these sRNAs and rpoS mRNA disrupts a hairpin in the untranslated
leader region of rpoS that blocks ribosome binding. The function of these sRNAs was tested in S.
enterica serovar Typhimurium under the same conditions reported to be important for their function in E.
coli. Neither DsrA nor RprA was required for rpoS regulation in S. enterica. Importantly, this work
demonstrates that sRNA function cannot be inferred from sequence conservation.
The second part of this thesis provides evidence for a model in which heme biosynthesis in S.
enterica is feedback regulated by heme at HemA, the enzyme catalyzing the first committed step of the
pathway. HemA is primarily regulated by conditional stability, becoming more stable in response to
heme limitation and subject to rapid turnover by ClpAP and Lon proteases when not limited for heme.
The first 18 amino acids of HemA are sufficient for protease recognition, however other regions of the
protein are required for heme-responsiveness. Although examples of direct feedback inhibition by heme
exist in other organisms, the mechanism by which HemA is targeted for proteolysis in S. enterica is
unknown. A model in which heme functions as a proteolytic tag by directly binding HemA is supported
by the following: (i) Purified HemA from S. enterica contains bound heme, (ii) mutation of a single
cysteine residue (C170) results in purified HemA that lacks bound heme, and (iii) the C170A mutant
protein is stable in vivo.
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Introduction
Theoretically, one can make connections between any two proteins in a given cell if no limit is placed
on the number of intermediate steps and no constraints are imposed regarding physiological relevance or
experimental evidence. Although the proteins described in this thesis, RpoS and HemA, are important for
Salmonella virulence, are primarily post-transcriptionally regulated, and can theoretically be connected by
as few as four or five intermediate steps, this would be somewhat contrived. Therefore they will be
treated as separate entities since this was the manner in which they were experimentally approached.
If there is an underlying theme that unifies these topics it is that post-transcriptional regulation often
involves elaborate schemes, requiring complex coordination of multiple proteins and a diverse group of
molecules, which can include RNA, metal ions, gases, and other small molecules. Furthermore,
differential regulation of conserved genes between closely related organisms may be more prevalent than
currently recognized. Determining what accounts for reported differences in regulation of homologous
genes in E. coli and S. enterica may illuminate pathogen-specific mechanisms.
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Chapter 1: Literature Review: Small RNA regulators of rpoS
translation
RpoS
Exchangeable proteins called sigma factors are essential for promoter recognition by RNA
70

polymerase in prokaryotes. The “housekeeping” sigma factor, Sigma D (RpoD, σ ) is responsible for
transcription of most genes during normal growth. Bacteria also employ alternative sigma factors that
S

tailor the cell’s transcriptional response to certain stresses or environmental cues. RpoS (sigma S, σ ,
38

σ ) is the general stress and stationary phase sigma factor of Escherichia coli, Salmonella spp., and other
enteric bacteria, which directs RNA polymerase to transcribe genes belonging to a large regulon, the size
of which is second only to that of RpoD; constituting 10% of genes in E. coli (53). RpoS regulation is
complex, occurring at the levels of transcription, translation, proteolysis, and activity; and in response to
various stress signals, including low temperature, high osmolarity, carbon starvation, and low pH
(reviewed in 14). This has earned RpoS the title “the master regulator of the stress response.”

rpoS alleles and virulence of Salmonella isolates
Pathogens experience a variety of stresses within the host environment (reviewed in 43). In mice,
infection with Salmonella enterica serovar Typhimurium (hereafter referred to as S. enterica), results in a
typhoid-like disease, which provides an effective animal model for the human-specific pathogen
Salmonella enterica serovar Typhi (9). S. enterica rpoS mutants are attenuated for virulence in mice (9).
Attenuation is attributed to the requirement for RpoS in regulation of genes located on the virulence
plasmid, and expression of genes necessary for survival within macrophages (7, 9).

2

S. enterica LT2 has been widely used in genetic studies since its original isolation in the 1940s,
however the LT2 strain is attenuated for virulence in mice due to a defective rpoS allele (50, 54). The
rpoS start codon in LT2 is a non-optimal UUG, as opposed to the AUG start in virulent isolates, such as
SL1344 and ATCC 14028s. Virulence can be restored to LT2 by replacement of its rpoS allele with that
of a virulent strain, or by mutation of mouse virulence gene A, mviA (2, 50). Mutations in mviA result in
increased stability of RpoS due to defective turnover, which partially compensates for the lower
expression level (2). These observations illustrate the importance of cellular RpoS levels in S. enterica
virulence, indicating a requirement for strict regulation in response to stress.

Transcription of rpoS
The rpoS promoters of E. coli and Salmonella enterica serovars Dublin and Typhimurium have been
characterized (15, 21, 36). The rpoS gene is transcribed from two promoter regions; two closely spaced
and relatively weak promoters upstream upstream of the adjacent nlpD gene, and the major rpoS
promoter, PrpoS, located approximately in the middle of the nlpD gene (Fig 1A). Transcription from
PrpoS generates a monocistronic rpoS transcript with a 565-nt 5′ untranslated leader region (5′UTR). The
-35 and -10 hexamers, the length of the 17 bp spacer, and the transcription start site are identical in
Salmonella and E. coli (15, 21, 36).
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Figure 1. Transcription of rpoS from PrpoS (A), yields a transcript with a long 5` untranslated leader region, which
contains an antisense element (B). (A) Two rpoS promoter regions. The PnlpD promoters produce basal levels of rpoS.
The major promoter, PrpoS. (B) Nucleotides immediately upstream of the start codon (shaded in grey) base pair with an
upstream antisense element (overlined) forming three stems. The Shine-Dalgarno (S.D.) sequence is looped out between
stems II and III, which blocks ribosome binding. The open circle represents 63 omitted nts.

The antisense element model of rpoS regulation
Within the 5′UTR of rpoS mRNA, base pairing between nucleotides immediately upstream of the
initiation codon and an upstream antisense element results in the formation of three stems (Fig. 1B).
Stems II and III flank the Shine-Dalgarno (S.D.) complementarity to 16S rRNA and ribosome binding is
inhibited. Therefore, the default state for translation is ‘off’. This model is supported by in silico
structural modeling and genetic analyses incorporating point and compensatory mutations of predicted
pairing partners within stems (6, 8, 18, 27). With the exception of the start codon, the nucleotides within
the hairpin are completely conserved between E. coli and S. enterica.

4

Evidence for the antisense element
The antisense model was first proposed by in silico structural modeling of E. coli rpoS mRNA and
recognition of its apparent similarity with rpoH mRNA, which was known to be under antisense control
(20). Although the proposed structure was incorrect, subsequent reports by Elliott and coworkers
supported an antisense mechanism of regulation. In both E. coli and S. enterica, RpoS levels are
dramatically reduced in hfq mutants as a result of inefficient translation (5, 35). Authors speculated that
Hfq, an RNA binding protein, regulates rpoS translation by altering the proposed antisense structure (5).
In S. enterica, suppressor mutations that decrease the in vivo dependence of rpoS-lac expression on Hfq
were identified. Most mapped to stems II and III (6).
Further evidence for the structure was obtained by a genetic analysis of the central GC pairs of SII
and SIII. The rationale directing this analysis is that if pairing alone is important for Hfq function, then
single changes will confer a mutant phenotype, but a double mutant has compensatory changes that allow
pairing, and will restore the wild-type phenotype. The single stem II mutants, C126G and G206C,
exhibited increased rpoS-lac expression and decreased dependence on Hfq; the C126G/G206C double
mutant strongly resembled wild type (6). However, for both E. coli and S. enterica, single mutations
within the upper strand of stem III result in a mutant phenotype, but the suppressing effect of the
compensatory mutation is incomplete (6, 18).

Hfq binding sites in rpoS mRNA
Hfq preferentially binds A/U-rich sequences, usually flanked by one or more hairpins (4, 55).
Although the effect of Hfq on rpoS translation is localized to the antisense element, Hfq doesn’t directly
bind at this site (25). The Hfq-responsive element within the rpoS leader is located >100 nts upstream of
the antisense element (8). A stretch of 11 single-stranded nts containing AAYA repeats is located
5

approximately 100 nts upstream of the antisense element and is necessary for sensitivity to Hfq (48).
Other proposed binding sites include a stretch of unpaired nts (5′UUAUU) within the 63 nt loop adjacent
to the antisense element (Fig. 1B), and the sequence 5′AUUUUG just opposite the AUG codon (25).
How these sites contribute to rpoS regulation is unclear. However, an important discovery helped bridge
the apparent regulatory gap between rpoS and Hfq; the fortuitous identification of small noncoding RNAs
(sRNAs) that regulate rpoS in an Hfq-dependent manner.

Small noncoding RNAs (sRNAs)
Small noncoding RNAs (sRNAs), many of which are expressed in response to a specific
environmental cue, function by modulating the translational efficiency and/or stability of their mRNA
target(s) (13, 30, 40, 52). An sRNA typically contains a stretch of ~10 to 25 nucleotides that has the
potential to pair with its target, although in some cases it has been experimentally determined that only a
core subset of these are necessary for regulation (reviewed in 12). Base pairing between sRNA and
mRNA is dependent on Hfq (12, 52). Many sRNAs are highly conserved in closely related bacteria,
suggesting an important function (12). Most regulation mediated by sRNAs is negative, resulting in
inhibited translation, enhanced degradation, or a combination of these.

Hfq roles in sRNA-mediated regulation
A well-documented role for Hfq is stabilization of sRNAs. Several sRNAs exhibit decreased stability
in an hfq mutant background and many accumulate at lower levels (31, 34, 47, 51, 56). Like Hfq, RNase
E targets A/U-rich sequences with adjacent secondary structure (19, 26). In some cases Hfq stabilizes
RNAs by blocking cleavage sites (31, 33, 56). Hfq also facilitates RNA-RNA interactions. Hfq has two
independent RNA-binding surfaces (1, 32) and it has been demonstrated that Hfq can form stable ternary
complexes with two RNA strands (48, 55). Hfq is proposed to promote annealing by increasing the local
6

concentration of RNAs (32, 49). It has been reported that Hfq effects structural changes in some RNAs
and may facilitate RNA-RNA strand exchange (1, 11, 33). Finally, Hfq is known to associate with many
proteins, including components of the ribosome and the degradosome and it has been suggested that Hfq
may recruit these as part of its regulatory function (reviewed in 3).

sRNA-mediated regulation of rpoS translation in E. coli
In E. coli, DsrA and RprA activate rpoS translation in an Hfq-dependent manner in response to low
temperature and osmotic shock respectively. A role for RprA in cell envelope stress is suggested by a
largely RprA-dependent increase in rpoS expression in response to a constitutive rcsC allele (39, 40).
These sRNAs function via an anti-antisense mechanism. Both contain short stretches of complementary
sequence to the same region of rpoS and activate translation by base pairing with the antisense element.
This disrupts the hairpin and opens the translation initiation region to ribosomes (12, 13).
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Figure 2. The secondary structure of S. enterica DsrA (A) as modeled by the Vienna RNA server (16). The shaded A in
SL- is known to be important for binding rpoS in E. coli (28). (B) DsrA binds rpoS in the region of the antisense element.
The U:G pair in stem II is one of several tested by point and compensatory mutation (6).

E. coli and S. enterica: conservation of rpoS, dsrA, and rprA
It has been suggested that a high degree of sRNA sequence conservation in closely related bacteria
indicates conserved function (12). DsrA and RprA functions were initially characterized in E. coli (27,
29). The sequence of dsrA in S. enterica shows eight substitutions and three missing nucleotides
compared to E. coli (≈90% identity), and these changes do not result in significant alteration of the DsrA
structural model (18, 23, 35). With only three substitutions over 107 nts, the S. enterica rprA gene
8

exhibits even higher identity to its E. coli counterpart (18). The nucleotides of both sRNAs that interface
with rpoS are completely conserved between E. coli and S. enterica (18).

DsrA regulates two global regulators in E. coli
DsrA is the best-characterized sRNA regulating rpoS. DsrA is an 85-nt sRNA initially discovered in
E. coli as a multicopy activator of capsule synthesis (cps) genes. Transcription of the rcsA gene, which
encodes an unstable positive regulator of cps genes, is silenced by H-NS (45). H-NS is a global regulator
and represses the expression of at least 250 genes (17). DsrA overexpression decreases H-NS levels by
inhibiting its translation (22). The discovery that DsrA also regulates rpoS identifies DsrA as a regulator
of two global regulators, perhaps serving to fine-tune the response to stress signals in which RpoS and
HNS act antagonistically.

Different stem-loops of DsrA regulate rpoS and hns in E. coli
In vitro structure probing and computer-assisted modeling have predicted no less than three structures
for DsrA. In all proposed models, DsrA is configured into three stem-loops (Fig. 2A); the first and third
are relatively stable and similar in all models, while the second is unstable and predicted to form
alternative structures (42). A mutational dissection of DsrA revealed independent functions for each stemloop. In general, stem-loop 1 (S-L1) regulates rpoS, S-L2 regulates hns, and S-L3 is a transcriptional
terminator (23, 24). DsrA activates rpoS translation by direct interaction with rpoS mRNA (Fig. 2B; 27,
29). Plasmid-expressed constructs of dsrA either deleted for S-L1 (ΔS-L1) or with an NcoI site
introduced between S-L1 and S-L2 failed to induce an rpoS-lacZ translational fusion. Activity was
restored by compensatory mutations in rpoS. Anti-H-NS activity was maintained in the ΔS-L1 and NcoI
DsrA mutants, demonstrating the functional and structural separation of this activity (27). These analyses
defined sequence and structural elements necessary for regulation of DsrA’s two targets, demonstrated the
9

requirement for direct pairing between DsrA and rpoS in activating rpoS translation, and provided further
support for the structure of the antisense element.

DsrA regulation of rpoS in E. coli vs. S. enterica
A link between rpoS and DsrA was discovered in studies directed at determining a role for DsrA
when expressed at physiological levels (46). Expression of a dsrB::lacZ transcriptional fusion increased
+

in stationary phase, indicative of RpoS regulation, and increased at low temperatures in a dsrA host.
Decreased dsrB::lacZ expression in a dsrA mutant was determined to be an indirect effect mediated by
decreased RpoS synthesis. Using a combination of rpoS::lacZ fusions and Northern and Western blot
analyses, it was determined that increased levels of RpoS at low temperature (≤30°C) in exponential
phase is dependent on DsrA translational activation of rpoS mRNA (46). In S. enterica, a modest (≈2fold) induction of RpoS expression at 18°C compared to 37°C is independent of DsrA and RprA (18).

The dsrA promoter: E. coli vs. Salmonella
At low temperatures (below 37°C), DsrA levels in E. coli increase due to a combination of
increased transcription from the dsrA promoter and increased stability (38). Following the initial
discovery that the minimal 36-bp promoter is sufficient for temperature regulation (38), it was determined
that an unusual -10 box (TAAGGT) and an AT-rich 17-bp spacer were critical elements within it (39).
The -35, -10, length of the spacer and sequence of the AT-rich motif are conserved between E. coli and S.
enterica, suggesting that the dsrA promoter in S. enterica should exhibit equivalent temperature
induction. However, in Salmonella, a dsrA::lacZ transcriptional fusion was induced only 2.5- to 3-fold at
18°C versus 37°C (18) compared to the 6-fold increase at 25°C versus 42°C reported for the E. coli dsrA
promoter (38).
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Regulation of DsrA stability in E. coli
Determination of DsrA levels by Northern analysis revealed two DsrA bands; one corresponds to the
full-length sRNA (F form, ~85 nts), and the second is a truncated species (T form) of ~60 nts. The T
form, which is detected by Northern blot using a probe complementary to S-L2, but not S-L1, is likely a
processing product of RNase cleavage (38). Hfq is required for DsrA-mediated regulation of both rpoS
and hns (47). In an hfq mutant background, DsrA is 6-fold less stable than wild type and only the
truncated form of DsrA is detected. In vitro, Hfq specifically interacts with DsrA, protecting select nts
from RNase cleavage (47). Both RNase E and RNase III have been implicated in DsrA-mediated
ts

regulation of rpoS. At the non-permissive temperature, the steady-state levels of DsrA in an rne strain
(temperature sensitive RNase E mutant) are increased and the F form is the dominant species (33). In
vitro, RNase E cleaves DsrA at nt A28, but only in the absence of Hfq (33). Resch and coworkers
proposed a model in which pairing of DsrA with rpoS eliminates detrimental RNase III cleavage at two
positions upstream of the S.D. sequence, and creates a new cleavage site rpoS in the strand opposite the
intiation codon (41). DsrA itself is cleaved between A28 and A29 dependent on association with rpoS,
thus providing a mechanism for DsrA de-activation.

DsrA expression: E. coli vs. S. enterica
In E. coli, DsrA is easily detected by Northern blot using probes complementary to S-L1 (F form) and
S-L2 (T form). Overexpressed DsrA, of either E. coli or S. enterica origin, is detected in an E. coli dsrA
mutant by Northern blot using a probe to S-L1. Chromosomal DsrA is also detected in wild type E. coli
when samples are prepared from cultures incubated at 18°C. In contrast, DsrA from either source was
undetectable in all conditions tested in S. enterica (18).
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RprA: a second sRNA positively regulating rpoS translation
RprA was discovered in E. coli as a multicopy suppressor of dsrA mutants (28). RprA levels increase
in response to osmotic shock (28) and a constitutive rcsC allele, indicating a role cell envelope stress (10,
29). RprA has fewer complementary nucleotides when paired with rpoS mRNA than DsrA, with the
longest region of complementary sequence (11 out of 13 nt) lying between A33 and U45 of RprA. Using
DsrA as a model, Majdalani and co-workers investigated the role of RprA as an activator of rpoS
translation. RprA directly interacts with rpoS mRNA. This was demonstrated by the mutant phenotype of
point mutations in RprA that are restored to wild type by compensatory mutations in rpoS (29).
Furthermore, DsrA and RprA bind the same region of the rpoS mRNA to stimulate rpoS translation (29).

Regulation of rpoS in response to osmotic shock and a constitutive rcsC allele
In an E. coli dsrA mutant, the basal level of rpoS-lac activity was reduced compared to wild type, but
induction in response to sucrose challenge was unaffected. Induction was nearly absent in the dsrA rprA
double mutant (27, 28). In contrast, an S. enterica dsrA rprA double mutant was no more defective than
the single dsrA mutant in response to osmotic shock (18). In E. coli, RprA and RpoS::LacZ levels are
increased 50- and 20-fold respectively by a constitutive rcsC allele (29). In S. enterica, a modest, 2.5- to
3-fold increase in rpoS-lac expression by an rcsC allele was independent of RprA (18).

Discussion
Examination of DsrA- and RprA-mediated regulation of rpoS in S. enterica was undertaken to
address the general question: Can conservation of sRNA function be inferred from a high degree of
sequence conservation? The primary sequences of dsrA and rprA in E. coli and S. enterica are ≥90%
identical. Also, the region of rpoS targeted by these sRNAs is, with the exception of the start codon
(AUG in E. coli, UUG in S. enterica), completely conserved. The function of these sRNAs was tested in
12

S. enterica under the same conditions reported to be important for their function in E. coli. Neither DsrA
nor RprA was necessary for the relatively modest increases in RpoS expression seen in S. enterica at low
temperature (18ºC) in response to osmotic shock, or cell envelope stress as tested in the context of a
constitutive rcsC allele (18). The incongruity of these results begs the question: why are these genes
maintained at such fidelity?
It is not uncommon for an sRNA to regulate more than one target (37). Although not required for
increased rpoS translation in S. enterica, DsrA has at least one other target, HNS (45). Using a probe
specific for stem-loop 1 (S-L1), DsrA was undetectable by Northern blot in S. enterica, suggesting rapid
degradation (18). Although untested, Northern analysis of the same samples using a probe specific for SL2 might have yielded a signal corresponding to a truncated form as previously observed for E. coli (47).
In E. coli, the truncated form of DsrA is defective for stimulating rpoS translation, but maintains most of
its anti-H-NS activity (27). Therefore, it is possible that DsrA function is conserved in S. enterica with
regard to H-NS.
An alternative explanation is that DsrA regulates rpoS in S. enterica, but perhaps requires an
additional stimulus. The demonstration that overexpressed S. enterica DsrA is nearly as capable as
overexpressed E. coli DsrA in activating rpoS translation in E. coli supports this possibility (18).
Furthermore, Sittka and coworkers, attempting to verify predicted sRNAs as well as isolate novel sRNAs,
reported that both DsrA and RprA were expressed and associated with Hfq in S. enterica serovar
Typhimurium isolate SL1344 (44). Employing anti-Hfq co-IP and high-throughput pyrosequencing,
DsrA and RprA were sufficiently enriched to predict detection by Northern blot would be possible,
although this was not attempted. The function of these sRNAs regarding rpoS or hns has not yet been
tested in SL1344, however association with Hfq indicates they are functional regulators. In conclusion, a
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high level of sequence conservation between sRNAs of related species may indicate an important
function, but it does not necessarily follow that it will be the same function in individual species.
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Abstract
RpoS, the sigma factor of enteric bacteria that responds to stress and stationary phase, is subject to
complex regulation acting at multiple levels including transcription, translation and proteolysis. Increased
translation of rpoS mRNA during growth at low temperature, after osmotic challenge, or with a
constitutively activated Rcs phosphorelay, depends on two trans-acting small regulatory RNAs (sRNAs)
in Escherichia coli. The DsrA and RprA sRNAs are both highly conserved in Salmonella enterica, as is
their target, an inhibitory antisense element within the rpoS untranslated leader. Analysis of dsrA and
rprA deletion mutants indicates that while the increased translation of RpoS in response to osmotic
challenge is conserved in S. enterica, dependence on these two sRNA regulators is much reduced.
Furthermore, low temperature growth or constitutive RcsC activation had only modest effects on RpoS
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expression and these increases were, respectively, independent of dsrA or rprA function. This lack of
conservation of sRNA function suggests surprising flexibility in RpoS regulation.

Introduction
RpoS, the general stress and stationary phase sigma factor, is highly conserved among Escherichia
coli, Salmonella enterica, and other related enteric bacteria. The diverse and often harsh conditions
encountered by these bacteria, whether residing as pathogens in the gut or as saprophytes in the
environment, require the ability to integrate multiple stress signals and initiate the appropriate cellular
responses in order to survive. RpoS serves in this capacity as the master regulator of the general stress
response. Its levels increase in response to a number of stress signals, including osmotic shock, nutrient
depletion, low temperature, and growth into stationary phase (reviewed in reference 19). As RpoS
becomes more abundant, it effectively competes with the vegetative sigma factor in binding RNA
polymerase, leading to increased transcription of genes necessary for mediating the stress response (48).
Regulation of RpoS is complex, with a large post-transcriptional component, and involves transacting factors (19). These factors include several small regulatory RNAs (27,38), which target a cisacting antisense element within the rpoS mRNA untranslated leader (7). In E. coli, two such small RNAs
(sRNAs), DsrA and RprA, activate rpoS translation by pairing with rpoS mRNA and disrupting the
antisense element (reviewed in reference 28). DsrA is necessary for activation of rpoS translation in
response to low temperature and osmotic shock (30), while RprA increases RpoS both in response to
osmotic shock (29) and to a constitutively active rcsC allele, indicating a role in cell envelope stress (15,
29).
These sRNAs were initially discovered and characterized in E. coli, and their gene sequences are ≈
90% identical in S. enterica. The high degree of sequence conservation shared by E. coli and S. enterica,
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in both rpoS and the sRNAs, suggests that their regulatory function is likely to be conserved as well. Here
we describe the results of experiments undertaken to characterize the roles of DsrA and RprA in S.
enterica, specifically their effect on rpoS regulation. Our findings strongly suggest that, under the
conditions tested, neither of these sRNAs is required for optimal RpoS synthesis in S. enterica.
Mutational analysis of the rpoS antisense element in S. enterica was also performed to further
characterize the role of secondary structure in RpoS synthesis. The results of this analysis are broadly
comparable to those in E. coli.

Methods
Bacterial strains and growth conditions.
The bacterial strains used in this study are listed in Table 1. The katE-lac operon [op] fusion used in
this work has been described previously and is a reporter of RpoS activity (6, 10, 21). Isolation of Mud
insertions and construction of site-specific mutations is described below. The high-frequency generalized
transducing bacteriophage P22 mutant HT105/1 int-201 was used for transduction in S. enterica by
standard methods (12). Phage P1 vir was used for transduction in E. coli, also by standard methods (40).
Bacteria were grown in media and at temperatures which are described for each individual experiment.
LB was used as rich medium (40), and the minimal medium was MOPS (morpholinepropanesulfonic
acid; 34) as modified (4). Plates were prepared by using nutrient agar (Difco) with 5 g of NaCl per liter.
Antibiotics were added to rich medium to final concentrations as follows: 20 µg of tetracycline
hydrochloride per ml, 20 µg of chloramphenicol per ml, 50 µg of kanamycin sulfate per ml, 200 µg of
streptomycin sulfate per ml, and either 100 µg of sodium ampicillin per ml for high copy plasmids, or 30
µg per ml for low copy plasmids. In minimal medium, kanamycin sulfate was added to a final
concentration of 100 µg per ml.
24

Isolation and analysis of rpoS-lac fusions formed by insertion of Mud transposons.
Insertions of MudJ (MudI 1734) to form operon fusions and MudK to form protein fusions (1, 8)
5
were obtained by screening large pools of insertions (>10 clones) for linkage to the rpoS region. Since

rpoS is very close to cysC (6 kb separate the two genes), a phage P22 transducing lysate grown on each
R
+
insertion pool was used to transduce TE8607 (Δ cysC::tet) to Kan Cys on plates containing X-gal.

Blue colonies were picked, purified once on selective medium, patched onto NB agar containing
kanamycin, and tested for an rpoS mutant phenotype by scoring formation of bubbles when spotted with 5
µl of 3% hydrogen peroxide. Insertions were mapped by PCR, and the precise joint with the Mud
element was located by DNA sequencing. The starting insertion pools were isolated by mutagenesis of S.
enterica LT2 using the method of Hughes and Roth (22). The original host for MudK insertions carried a
plasmid unrelated to the current project (pRF1; 14), therefore, backcrossed candidate insertions were
checked to confirm that this plasmid had been lost as expected.
Preliminary characterization showed both expected and unexpected properties for strains carrying
these fusions. Fusions were recovered within rpoS but also in the upstream region encoding the Cterminal part of nlpD. Polarity of the insertions lying within this part of nlpD on expression of rpoS is
consistent with the location of the major rpoS promoter roughly in the middle of the nlpD gene (21, 23,
45). Also as expected, all lac protein fusions to rpoS tested were found to be substantially (≈ 4- to 5-fold)
dependent on function of the hfq and dksA genes, known from previous studies to affect rpoS translation
but not transcription (6, 33, 47). Sensitivity to clpX and mviA mutations was tested in the LT2A
background (9). The effect of mutations blocking the protein turnover pathway was variable depending
on the location of the insertion site within rpoS. The MudK insertion at rpoS codon 22 was unaffected by
loss of clpX or mviA, whereas expression of the insertion at codon 250 was increased 5- to 6-fold in both
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clpX and mviA mutant backgrounds during exponential phase in LB medium. This behavior is consistent
with identification of K173 as a critical residue in the RpoS “turnover element” in E. coli (2). In
stationary phase, expression of sensitive rpoS-lac protein fusions became independent of clpX and mviA.
Other results in S. enterica (21) show that this behavior is not characteristic of the RpoS protein itself or
of RpoS-dependent reporters. We can explain this result by postulating that the rpoS-dependence of mviA
(rssB / sprE) expression during stationary phase found in E. coli (39) is conserved in S. enterica.
+
One unexpected result was that several MudK insertions in rpoS (screened as dark blue Lac colonies

on X-gal plates) were found to be out-of-frame but express lac as strongly as in-frame fusions.
Remarkably, an insertion in the +1 frame at codon 36 expressed lac at a 3-fold higher level during
exponential phase than any in-frame fusion recovered. Several high-expressing out-of-frame fusions
were confirmed to have the predicted sequence across Mu and into the first 300 bp of lacZ. The
explanation for this unusual situation is likely that: (i) exponential-phase expression of in-frame rpoS-lac
protein fusions is quite low (≈ 10-fold lower than any rpoS-lac operon fusion), due at least in part to the
action of the antisense element; and (ii) the sequence at the joint with MudK consists of the in-frame
codon XTG, where X is contributed by rpoS and TG is from Mu. The sequences of all high-expressing
out-of-frame insertions contained a plausible ribosome-binding site (RBS) upstream from an initiation
codon. This suggests that the high relative expression of out-of-frame fusions is an artifact due to the
novel sequence at the insertion joint.
A second puzzling and cautionary result comes from comparison of MudJ (operon) fusions upstream
and downstream of the rpoS initiation codon. We found that two early fusions, one within nlpD at +9
with respect to the rpoS transcriptional start, and the other at +276, showed no stationary phase induction
in LB medium, whereas later fusions at codon 36 and codon 222 showed normal induction. This behavior
indicated that normal regulation depends on sequences substantially downstream of the promoter.
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However, leader-dependent regulation is not consistent with our previous study of SP induction (21),
which showed that a short segment surrounding the promoter region displayed the full range of SP
regulation of transcription.

Figure 3. Comparing the regulation of lac operon fusions formed by MudJ insertion or plasmid integration. Panel A.
The rpoS coding sequence (bold line) and upstream leader are indicated, with labels indicating four sites at which fusions
were isolated or constructed as described in the text. These positions are: 1 (+9 of the leader), 2 (+276 of the leader), 3
(codon 36 of rpoS) and 4 (codon 222 of rpoS). Panel B. Analysis of lac expression from MudJ insertions at sites 1-4.
Open bars indicate exponential phase cultures and filled bars indicate stationary phase (SP) cultures, as defined in the
text. SP induction of rpoS transcription is measured as the ratio of the value from the filled bars to open bars. Panel C.
The same as panel B, except that each fusion was made by integration of plasmid pKG137, as described in the Methods.
Strains for panel B were: TE8804, TE8935, TE8936, and TE8794. Strains for panel C were: TE9052, TE9049, TE9050,
and TE9051. Each bar represents the average of at least three experiments. Standard deviations were within 15% of the
mean.
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To resolve this issue and map the apparent discontinuity, a number of precisely targeted lac operon
fusions were constructed using the method of Ellermeier et al. (13). In this method, the λ Red
recombination system is used to direct insertion of a drug resistance marker flanked by directly repeated
FRT sites into the bacterial chromosome. The insertions are then resolved to leave a single unmarked
R
FRT site, which is targeted for Flp / FRT-mediated integration of a replication-defective Kan plasmid to

provide the lac genes and form either an operon or a protein fusion. The lac fusions used here were
constructed with pKG137 (M. Garsha and J. Slauch, personal communication), a plasmid that forms lac
operon fusions including a strong RBS for lacZ. As shown in Fig 3, the fusions made by this method at
+9 and +276 with respect to the transcriptional start were regulated, in contrast to the behavior of MudJ
fusions inserted at exactly the same sites. The different behavior of MudJ insertions is currently
unexplained, but presumably depends on the nature of the extra sequences present at the attR end of
MudJ, including about 400 bp from Mu as well as a substantial segment of the E. coli trp operon.

Plasmid pTE780 (PBAD-S. enterica dsrA) was constructed by PCR using the following primers: 5´GCGGGATCCTACCTGACGCTTTTTATCGCAACTCTCTACTGTTTCT
CCATCACATCAGATTTCCTGGTGT-3´, and 5´-GCGTCTAGAACCG TTAAAAAGGC CGAAA-3´ on
LT2 DNA as template. Sequences from dsrA are shown in italics. The PCR product was purified,
digested with BamHI and XbaI and cloned into pBAD18 (18).
Construction of insertion and point mutations using λ Red recombination. Other point
mutations and insertion / deletions were made by direct transformation of S. enterica, either with
oligonucleotides or with DNA segments amplified by PCR, utilizing the λ Red recombination system as
provided on plasmid pKD46 (11). Exponential-phase recipient cells carrying pKD46, grown at 30°C with
R
selection for ampicillin resistance (Amp ), were induced by treatment with 0.2% arabinose for one hour
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before electroporation, after which transformants were grown out in liquid medium before plating and
selection at 37°C. A few experiments utilized pSIM5, a plasmid for mutant construction based on the
method of Yu et al (50) and obtained from D. Court.
Most of the unmarked point mutations were obtained as follows. First, an insertion of tetAR near
or at the target site was isolated. Subsequently a recipient bearing that insertion and induced for λ Red
R
was transformed with a mutated oligo and selection applied for loss of Tet (Bochner selection; 5,31).

For unknown reasons, this selection has a high background for insertions at certain sites. For insertion
within the rpoS RBS, it was important that the recipient strain also contained katE-lac [op], an RpoS+
dependent reporter fusion. Replacement of the tetAR cassette restored a Lac phenotype, visualized by

subsequent single colony isolation on MacConkey lactose agar. Some double mutants with lesions
affecting both the antisense element and the RBS region were constructed by an iterative procedure in
which a tet insertion derivative of an existing point mutant was constructed as an intermediate. A second,
more rapid method used a singly mutant DNA template (lesion in the RBS) for PCR to introduce the
second mutation, which was recovered by transformation of a recipient deleted for the region between the
antisense element and the RBS. This deletion, marked with tetAR, was from strain TE8701
(∆rpoS1080::tetAR).
A mutation changing the rpoS TTG start codon to ATG was obtained by oligo transformation as
described above, but a second mutation changing the TTG to TCG could not be screened in the same way
+
since it does not confer a Lac phenotype. To make this change, we designed and constructed a different

counter-selectable insertion in the RBS region of rpoS, based on the known dominance of wild type rpsL
S
S
R
(Str ) in merodiploids containing one Str and one Str allele, as exploited by others (41). First tetAR
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+
S
was inserted just upstream of the rpsL gene of an Str E. coli strain. Chromosomal DNA from this
+
strain (TE9062) was used as template to amplify a tetAR-rpsL cassette and this DNA segment was then
+
inserted at the RBS of S. enterica rpoS. TE9179, carrying both the rpoS::[ tetAR-rpsL ] insertion and the
R
S
strA1 (Str ) allele, was found to be Str as expected. For unknown reasons the strain forms small

colonies on NB agar lacking streptomycin, but this slow growth phenotype appears to be stable.
R
Transformants were easily obtained by selecting Str in this background, again using λ Red
S
recombination. The vast majority of these were Tet when mutated oligonucleotide DNA was added to

the transformation; three candidate transformants were sequenced and all contained the TTG to TCG
change.
Point mutations were backcrossed by transduction of recipient strain TE8607 (ΔcysC::tetAR
+
R
∆rpoS1076::cat), selecting Cys and screening for loss of the Cam marker in the rpoS leader. Double

mutants carrying both a lac fusion and linked point mutation were constructed by transduction using a
R
donor strain carrying the lac fusion (marked with Kan ) and the ΔrpoS1084::tetAR insertion, into a
R
+
S
recipient bearing the desired point mutation. The desired class of transductants was Kan Lac Tet .

The rpoS leader genotype of each recombinant strain was confirmed by DNA sequencing.
Targeted insertion / deletions of several genes were made by the λ Red method. The extent of
deletion for each construct is as follows: ΔcysC deletes 11 bp of the leader including the RBS precisely to
the stop codon; ΔdsrA deletes from the –35 hexamer of the promoter through the terminal polyU
sequence (2068766–2068651 of Genbank NC_003197); ΔrprA also deletes from the –35 hexamer of the
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promoter through the terminal polyU sequence (1444972–1444822 of Genbank NC_003197). For
reference, the rpoS leader extends from 3067051–3066487 of Genbank NC_003197.

β-galactosidase assays. Cells were centrifuged, resuspended in Z buffer (100 mM KPO4 [pH 7.0],
10 mM KCl, 1 mM MgSO4), and then permeabilized by treatment with sodium dodecyl sulfate (SDS)
and chloroform (32). Assays were performed in Z buffer containing 50 mM β-mercaptoethanol. Usually,
reactions were carried out in microtiter (96 well) plates and read in a Molecular Devices plate reader.
Activities (change in optical density per minute at 420 nm) were normalized to cell density (OD650) and
were always compared with activities of appropriate controls assayed at the same time. For experiments
involving cultures grown to different densities, the number of cells harvested was adjusted to provide
approximately equal cell densities in the assay. One unit of activity, as determined by this method, is
equivalent to ≈ 23 units as measured by the Miller assay (32). The latter assay is much more sensitive,
and was employed in selected experiments for this reason.
Immunological detection of proteins. Cultures were grown as described in the figure legends.
Exponential phase samples were taken at an OD600 ≈ 0.13, and stationary phase (SP) samples were taken
after 24 hours or 48 hours for cultures growing at 37°C or 18°C respectively. Protein samples were
prepared from 1-ml culture volumes by centrifugation and resuspension in 100 µl Tris / SDS buffer (5
mM Tris-HCl, 2% SDS). Samples were vortexed and then boiled for 10 minutes, centrifuged for 30
minutes, and the supernatants collected and stored at -20°C. The total protein concentration of each
sample was determined using a Lowry-based protein assay (Bio-Rad) according to the manufacturer’s
protocol. For each gel, protein samples were diluted in sample buffer to an equal concentration then
boiled for 5 minutes prior to loading onto 10 or 12% polyacrylamide mini-gels. Gels were loaded with
31

either 10 µg of total protein per well (SP protein samples) or 50 µg per well (exponential phase samples).
Electrophoresis was carried out at 75V for 2.5 hours and resolved proteins were transferred to a Sequiblot PVDF membrane (Bio-Rad) at 100V for 50 minutes using Bio-Rad’s Mini Trans-Blot Transfer Cell.
Subsequent steps and RpoS detection, using the R12 monoclonal antibody (6), were carried out as
previously described (21) with the following exception. Membranes prepared from stationary phase
protein samples, containing relatively higher levels of RpoS, were incubated for 2-3 hours with a
secondary antibody directly conjugated to HRP.
Northern blots. To detect DsrA, a probe (designated SL1) specific for the first stem loop of DsrA
was designed based on a probe used to study DsrA in E. coli (27). The SL1 probe is a single-stranded
biotinylated DNA oligo and has the following sequence: 5′ biotinAATCGTTACACCAGGAAATCTGATGTG.
Cultures were grown overnight, diluted 1:1000 into LB containing ampicillin and 0.02% L-arabinose,
and incubated at either 18 or 32°C. Total RNA was isolated from 1 ml of cultures grown to mid-log
phase using an RNeasy mini kit (Qiagen) according to the manufacturer’s protocol. RNA samples were
diluted to 1 µg in a final volume of 15 µl in glyoxal load dye (Ambion) and incubated at 50-55°C for at
least one hour prior to loading onto 6% urea/polyacrylamide mini gels. Electrophoresis was carried out at
100V for 80 min in 1xTBE buffer.
Gels were assembled into a Bio-Rad mini trans blot unit and RNA was transferred to a Brightstar
membrane (Ambion) at 100V for 50 minutes in 1xTBE. The RNA was cross-linked with a UV crosslinker (Stratagene) using the autocrosslink function. Cross-linked membranes were incubated at 37°C in
10 ml of Ultrahyb-Oligo buffer (Ambion) for 2-4 hours, and then with the same buffer containing the SL1
probe at a concentration of 185 ng/ml. Hybridization was carried out overnight at 37°C. The blots were
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washed and developed using the BrightStar Biodetect non-isotopic kit (Ambion) according to the
manufacturer’s protocol.

Results
Conservation of dsrA and rprA gene sequences between E. coli and S. enterica. As noted
previously by the authors who first reported the functions of the dsrA and rprA genes in E. coli (27, 30),
these genes are highly conserved between E. coli K-12 and S. enterica LT2 as well as in certain other
enteric species. In fact, conservation of sequence is thought to have predictive value in the search for new
small regulatory RNA genes (16, 46). Both the dsrA and rprA genes reside at similar positions in the two
bacterial chromosomes. Each gene is flanked by the same neighboring genes.

Figure 4 Panel A. The RNA sequence of a segment of the 565 nt S. enterica rpoS leader RNA, starting at nt 456 (110 nt
upstream from the start codon), and folded to show pairing between the antisense element and the rpoS RBS region
(stems I, II, and III). Paired regions flank the Shine-Dalgarno (S.D.) complementarity to 16S rRNA and extend to the
start codon (UUG in S. enterica, AUG in E. coli). Nucleotides that differ between S. enterica and E. coli are marked by
filled circles. The antisense element and the RBS region are connected by 63 nt, which are not shown but indicated by the
oval. Panel B. Pairing is shown between the antisense element (extended by an additional 18 nt on the upstream side) and
two different sRNA regulators of RpoS: DsrA and RprA. Paired nucleotides are indicated by vertical lines, and spaces
have been introduced where needed to facilitate the alignment. The stems of the antisense element are overlined for
reference. The gray boxes indicate a hexameric sequence whose complementarity with the target RpoS RNA is essential
for sRNA function, as shown in E. coli (Majdalani 98, Majdalani 02). The DsrA sequence shown starts at +1, the RprA
sequence starts at +28.
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The primary sequence of S. enterica dsrA shows eight substitutions and three missing nucleotides
compared to its E. coli counterpart (≈ 90% identity), and these changes can be accommodated with
limited effect on the folded structure (42, 24). Furthermore, the nucleotides of DsrA RNA that are
predicted to pair with rpoS mRNA are completely conserved, as shown in Figure 4. The S. enterica rprA
gene shows even higher identity to its E. coli counterpart (three substitutions in 107 nts) and its interface
with rpoS mRNA is highly conserved as well. The promoter sequences of the two genes are also nearly
identical.
This conservation of sequence suggests that the functions of these two genes are important and also
implies these functions should be conserved between the two species. Therefore, we investigated the role
of these two sRNAs in regulation of S. enterica rpoS under three conditions shown to activate rpoS
expression in E. coli: low temperature (DsrA), osmotic shock (DsrA and RprA) and activation by RcsC
(RprA).
Effect of low temperature. Sledjeski et al. reported that growth at low temperature (20°C) has a
dramatic effect on rpoS in E. coli. Expression in exponential phase was reported to increase by ≈100-fold
compared to 42°C (43). This increase specifically required DsrA (43) and was a post-transcriptional
effect on synthesis, consistent with the known mode of action of overexpressed DsrA on RpoS at 37°C
(27). The effect of a dsrA mutation was less dramatic in stationary phase but still significant (8- to 10fold).
To study the role of dsrA and rprA in S. enterica, we characterized the effect of the deletion of
each gene separately, or both genes together, on expression of the RpoS-dependent reporter, katE-lac
[op]. This reporter was used because the level of expression of rpoS-lac [pr] fusions is very low in
exponential phase, particularly since the rpoS gene has a TTG start codon in S. enterica (see below).
Results obtained by assay of katE-lac were confirmed by Western blot of RpoS itself. As a positive
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control, we used the katE-lac reporter fusion in an E. coli MC4100 derivative that was either wild type for
dsrA or carried the dsrA1::cat mutation (43). As expected, little effect of dsrA loss was seen for cells in
+
exponential phase at 37°C, either in E. coli or in S. enterica (Fig 5, panel B). For dsrA E. coli cells in

exponential phase at 18°C, expression of katE-lac [op] was about 10-fold higher than at 37°C, and the
dsrA mutant showed ≈ 6.5-fold lower expression compared to wild type at 18°C (Fig 5, panel A). A
modest increase in reporter expression at low temperature was also seen in S. enterica (≈ 2-fold), but
there was no effect of deleting dsrA or rprA, either singly or together. Western blot analysis using a
monoclonal antibody specific for RpoS confirmed this finding (Fig 5, panels C and D). A dsrA mutation
has a large effect on RpoS levels and expression of katE-lac [op] at 18°C in E. coli, but not in S. enterica.
Additionally, the effect of the dsrA1::cat on rpoS-lacZ [pr] activity was assessed in E. coli as performed
previously by Sledjeski et al (43). In exponential phase at 18°C, the rpoS-lacZ activity of the dsrA

+

cells was ≈12-fold higher than at 37°C, and the activity of the dsrA1::cat cells was ~14-fold less than
wild type at 18°C.
The temperature response in E. coli results from a combination of ≈ 6-fold increased expression
from the dsrA promoter at 25°C compared to 37°C, as well as stabilization of the RNA at low temperature
(37). A lac operon fusion to the chromosomal S. enterica dsrA gene was constructed to test whether there
was a response similar to that of E. coli. We observed 2.5- to 3-fold higher expression at 18°C compared
to 37°C (Fig 5, panel E).
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Figure 5. Effect of low temperature on RpoS.
Cells carrying the RpoS-dependent reporter katElac [op] were grown in LB medium at either 18°C
(panel A) or 37°C (panel B) to early exponential
phase (OD600 = 0.18) and assayed for βgalactosidase activity. The S. enterica strains
used were wild type (TE6153), ∆dsrA (TE8608),
∆rprA (TE8610) and ∆dsrA ∆rprA (TE8613).
The E. coli strains were wild type (TE6897) and
∆dsrA (TE6913). The indicated strains were also
analyzed for RpoS protein by Western blot as
described in methods. Cells were grown to
exponential phase (panel C) or stationary phase
(panel D) in LB medium at 18°C. Panel E: a lac
operon fusion to the S. enterica dsrA gene was
constructed as described in Methods and its
expression was assayed by measuring βgalactosidase activity after growth to exponential
phase in LB medium at the indicated temperature.

TTG start codon for rpoS. Expression of S.
enterica rpoS is particularly low because the gene
starts with a TTG initiation codon (26), compared
to the ATG start found in E. coli. This is partially
compensated at the level of RpoS protein and
reporters such as katE-lac [op] by the mviA
V102G mutation which eliminates regulated
RpoS protein turnover (3, 9). We are not aware
of any protein sequence analysis that would
confirm the assignment of the initiation codon in either E. coli or S. enterica.
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The origin of this difference between E. coli and S. enterica lineages is not clear. The DNA
sequences of several LT2 isolates (stored frozen for many years) all show the TTG start (unpublished
data). On the other hand, rpoS from virulent Salmonella strains has an ATG start (49). Since it has
recently been found that N-terminal deletions of rpoS may retain substantial function (17, 36), we tested
the function of the S. enterica TTG initiation codon. Site-directed mutations changing the start codon
were substituted at the native rpoS locus in the bacterial chromosome as described in the Methods.
Substitution of TTG by ATG increased expression of an rpoS-lac protein fusion (codon 250) by ≈ 10fold, whereas substitution of TTG by TCG decreased expression by more than 50-fold. This genetic test
confirms that the predicted TTG start codon carries out this role for rpoS in S. enterica.
Osmotic shock. Sucrose challenge experiments were carried out following the protocol described by
Majdalani et al. (30). Cells with a single-copy rpoS-lac [pr] fusion were grown in LB medium at 30°C
and challenged with sucrose during early exponential phase. The lac fusion used for this experiment was
formed by insertion of MudK at codon 250 of the rpoS gene. In other backgrounds, this fusion can be
subject to the protein turnover control exerted by mviA / rssB / sprE and the ClpXP protease (data not
shown), but the “wild type” LT2 strain employed for this experiment is defective for this pathway (3, 9).
The signal from this lac fusion was increased by substituting an ATG start codon, as found in E. coli.
This change should not affect pairing with the antisense element and also did not affect induction of rpoS
by osmotic shock (data not shown).
Addition of sucrose causes cells to plasmolyse, reducing their cross-section for light scattering and
thereby resulting in decreased turbidity. Even without a change in lac expression, this decrease in
turbidity would result in an artifactual increase in β-galactosidase activity, if it were normalized to OD650
as is typically done. For this reason, following Majdalani et al., we plot the total β-galactosidase activity
from a fixed volume of cells versus the amount of protein in the same sample, as determined at various
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times after challenge. In Fig 6, panel A, the results from a representative experiment are given for
osmotic challenge of a dsrA single mutant, compared to wild type. In panel B, the same experiment was
carried out with a dsrA rprA double mutant, also compared to wild type. It can be seen that the response
to sucrose was reduced in the dsrA single mutant, but did not appear to be further reduced in the dsrA
rprA double mutant. Growth of the double mutant was apparently sensitive to sucrose, based on
decreased protein accumulation in the challenged culture, and this observation was reproducible.
The incomplete effect in the S. enterica double mutant contrasts with the results obtained for E. coli.
There, a dsrA knockout reduced basal rpoS-lac expression by about 7-fold (at 32°C), but the relative
induction of rpoS by osmotic shock was still nearly as high as in wild type (27). In contrast, induction
was almost eliminated for the dsrA rprA double mutant (data shown in Fig 6 of reference 30, estimated in
part). Combined data from a set of trials in S. enterica is shown in Fig 6, panel C. Each bar represents
the ratio of enzyme activity normalized to protein, comparing values from 45 min post-challenge to timezero. It can be seen that the double mutant retained substantial induction by osmotic shock although it
was noticeably decreased from the wild type level. The normalization to protein levels employed here is
technically demanding because of limited sensitivity of the small-scale protein assay as well as high
background (data not shown), and because the comparison made is between ratios of ratios (activity
divided by protein, at two different times).
Therefore we also analyzed the data in a simpler fashion, by calculating the ratio of total βgalactosidase activity in sucrose-challenged and control cultures at 45 minutes post-challenge. This
alternative approach confirms that the double mutant retained about two-thirds the induction seen in wild
type (data not shown).
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Figure 6 Effect of osmotic challenge on rpoS-lac. The lac
protein fusion employed was formed by insertion of the
transposon MudK at codon 250 of the S. enterica rpoS gene
(see Methods for details).

Cultures were grown in LB

medium at 30°C to early exponential phase, split into
duplicate cultures, and grown to OD600 = 0.12. Cultures
were challenged with prewarmed aliquots of either sucrose
dissolved in LB medium (addition of ≈1/5 volume of 2 M
sucrose to give 0.464 M final concentration, ≈ 16%), or LB alone. Samples were removed at time-zero and at 15, 30 and
45 min after challenge. Cells were concentrated and assayed for total protein and for β-galactosidase activity. Panel A
shows a comparison of wild type cells (squares) to a dsrA mutant (circles); sucrose-challenged cells are represented by
filled symbols. Panel B shows a comparison of wild type to the ∆dsrA ∆rprA double mutant under the same conditions.
Panel C shows data from a set of such experiments. Each bar represents the ratio of enzyme activities from the 45 min
and time-zero samples, where both values have been normalized to the corresponding protein concentration. Dark bars
represent sucrose-challenged cultures, and light bars are untreated controls. The strains used were wild type (TE9160),
∆dsrA (TE9213), and ∆dsrA ∆rprA (TE9219).
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Since growth of this mutant appears somewhat more sensitive to osmotic shock than wild type, the
value of two-thirds is actually a lower limit for the relative inducibility of the mutant. In summary, our
results indicate that in S. enterica osmotic induction of rpoS was decreased by about one-third in a dsrA
rprA double mutant, while the defect in the E. coli double mutant was nearly complete.
Effect of constitutive RcsC. The third characterized small RNA-mediated regulation of rpoS in E.
coli involves induction of RprA via the rcs phosphorelay system, which also regulates capsule synthesis.
As described by Majdalani et al. (29), in E. coli RprA RNA levels are increased about 50-fold by the
constitutive rcsC137 allele of the gene encoding the transmembrane sensor kinase RcsC. The recessive
nature of this allele (A904V) suggests that it affects a negative regulatory activity contributed by the
response regulator domain of this hybrid sensor kinase. RpoS-LacZ levels are increased more than 20fold by the same mutation and most of this increase is rprA-dependent. We tested two similar
constitutively active alleles of rcsC in S. enterica, rcsC55 (T903A) and rcsC64 (F473I), described by
Garcia-Calderon et al. (15). Otherwise isogenic strains were constructed carrying an rpoS::MudK
insertion (lac protein fusion at codon 22 of rpoS) and either wild type for rcsC or carrying one of the two
constitutive rcsC alleles. Subsequently, a deletion of rprA was introduced into each strain. Expression of
rpoS-lac was elevated 2.5- to 3-fold by both rcsC alleles (Fig 7), however deletion of rprA had almost no
effect on the activation. As a positive control for the effect of constitutive rcsC* mutations, similar
strains were constructed substituting the lac fusion with an insertion of MudJ (forms operon fusions) in
the gmm / wcaH gene, to monitor transcription of the capsule biosynthesis cluster. Activation of wcaH by
+
the mutant alleles of rcsC was at least 50-fold (expression in the wild type rcsC strain was below the

limit of detection for this assay). Although RprA was not previously observed to regulate capsule
synthesis, introduction of the rprA deletion reduced expression of wcaH-lac to about 60% of the level
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seen with wild type rprA. In summary, we do find ≈ 3-fold activation of rpoS expression by both of these
constitutive rcsC alleles, but there is no
evidence for involvement of the RprA RNA in
this response.
Testing the effect of overexpression of
DsrA on rpoS-lac. The experiments presented
in this paper do not support a significant role for
the DsrA and RprA RNAs in the regulation of
rpoS in S. enterica. One possible explanation is
that the few sequence differences between the
dsrA and rprA genes of S. enterica and E. coli
are responsible for this unexpected result.

Figure 7 Effect of activated rcsC on rpoS-lac. In the left half of
the figure, the lac protein fusion was formed by insertion of the
transposon MudK at codon 22 of the S. enterica rpoS gene. In
the right half, the lac fusion was the gmm-21::MudJ insertion
(also called wcaH; 15).

Therefore, we tested the function of S. enterica
dsrA more extensively by using the
overexpression phenotype described by

Two activated alleles of rcsC were

compared to wild type, and each set consisted of strains either
wild type or mutant for rprA. Cells were grown overnight to
stationary phase in LB medium at room temperature (23-25°C)
and assayed for β-galactosidase activity, normalized to OD600
as described in Methods. Results shown are the average and

Majdalani et al. (27). The dsrA gene from S.
enterica was expressed from the pBAD
promoter in plasmid pTE780, and a similar
plasmid, pNM3, carrying the E. coli dsrA gene

standard deviation for at least 7 independent experiments.
Strains for rpoS-lac were rcsC+ rprA+ (TE9317), rcsC+ ∆rprA
(TE9353), rcsC55 rprA+ (TE9316), rcsC55 ∆rprA (TE9352),
rcsC64 rprA+ (TE9318), and rcsC64 ∆rprA (TE9354). The
corresponding strains with the gmm-21::MudJ insertion were:
TE9334, TE9394, TE9333, TE9395, TE9368, and TE9396.

was tested in parallel (27). These plasmids
together with vector controls were introduced
into E. coli and S. enterica strains bearing appropriate rpoS-lac [pr] fusions. Cultures were grown
overnight at 32°C in LB medium with ampicillin, then diluted into the same medium containing arabinose
as the inducer and grown overnight to stationary phase. Preliminary experiments testing various levels of
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inducer showed that at high levels (0.2% arabinose) the empty vector controls displayed a significant
negative effect on rpoS expression. Because of this, the experiments described here were performed with
intermediate levels of arabinose (0.02%).
The results are shown in Fig 8, panel A. Expression of either E. coli or S. enterica dsrA in E. coli
resulted in significant induction of rpoS. There was an ≈ 8-fold increase in activity of rpoS-lac [pr] with
overexpression of the E. coli dsrA gene; for S. enterica dsrA the increase was slightly less, ≈ 6–fold. In
contrast, neither gene was able to activate rpoS expression in the S. enterica strain background. This
negative result in S. enterica, obtained using a MudK insertion in the native rpoS locus as the reporter,
was confirmed using a fusion construct identical to the reporter tested in E. coli: E. coli rpoS fused to lac
(8; data not shown). These results show that S. enterica dsrA is capable of activating rpoS expression in
E. coli.
Northern blot analysis of RNA purified from the induced cultures showed that DsrA RNA
expressed from PBAD was clearly visible in E. coli, but no signal could be detected in S. enterica (Fig 8,
panel B). The pattern of ribosomal RNA in all samples was normal (data not shown, 35). Furthermore,
arabinose induction of a PBAD -lacZ construct was observed in S. enterica, to approximately the level of
a fully induced single copy lac operon (data not shown). Failure to overexpress DsrA RNA of either type
in S. enterica suggests that the defect lies with DsrA RNA turnover, but allows the formal possibility that
S. enterica rpoS also fails to respond.
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Figure 8 Expression of dsrA from PBAD. Panel A. Strains
of E. coli or S. enterica with an rpoS-lac [pr] fusion in the
bacterial chromosome, deleted for dsrA, and also carrying a
plasmid PBAD -dsrA construct from the species indicated,
were induced with 0.02% arabinose and grown overnight to
stationary phase in LB Amp medium at 32°C. Activity of
β-galactosidase is plotted for each strain, normalized to the
expression seen with a vector control.

Panel B.

RNA

purified from cultures grown as in A was analyzed by
Northern blot as described in Methods, using a dsrAspecific oligonucleotide probe.

Strains were:

TE9418,

TE9419, TE9424, TE9425, TE9427, TE9428, TE9430, and
TE9431.

Mutations affecting the antisense element
and its RBS target in S. enterica rpoS. Our
previous studies on function of the antisense
element employed a lac fusion to the E. coli rpoS
gene and its upstream sequences (6). The effect of
point mutations on rpoS expression was studied
primarily in the S. enterica background (7), while the effect of deletion and overexpression of small RNA
genes has been studied in E. coli (43, 27, 51, 29). Therefore, we tested the effect of mutations changing
either the antisense element or the rpoS RBS in S. enterica. As described above, the sequence of the rpoS
leader is highly conserved in S. enterica compared to E. coli, particularly in the region between the
antisense element and the start codon (Fig 4). Even in the 63-nt connector region, which is predicted to
form two stem-loops (20), the eight substitutions found in S. enterica would affect loop nucleotides rather
than paired stem nucleotides (data not shown).
A number of point mutations were constructed directly on the bacterial chromosome using the λ Red
S
recombination system and selection for Tet transformants as described in the Methods, and combined
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with a MudK insertion in the rpoS gene to measure their effect on expression. Mutations in the rpoS
leader were studied in a strain carrying an insertion in the hfq gene for several reasons. First, an hfq
mutation is known to sensitize E. coli to the effect of similar mutations (7). This may be due to the
existence of other, as yet uncharacterized Hfq-dependent activating sRNAs, or it may be due to far
upstream elements of the rpoS leader which also have Hfq-dependent effects (10). A second reason to
use an hfq mutant is that interactions with other molecules might confound the interpretation of
phenotypes for strains with compensatory mutations.
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Figure 9. Effect of point mutations in the antisense element and RBS region on expression of rpoS in E. coli and S.
enterica. S. enterica strains with mutations in the rpoS leader on the bacterial chromosome were constructed as described
in Methods. The rpoS::MudK (codon 216) fusion and an hfq::Mud-Cam insertion were introduced by P22 transduction.
E. coli fusion strains have been described or were made in the same way (7). Cultures were grown overnight in LB
medium at 23-25°C to SP and assayed for β-galactosidase activity. Panel A shows the location of point mutations within
the antisense element. Strains used in panel B: TE6266, TE6557, TE6558, TE6590, TE6369-2, TE6369-3, and TE6382.
Strains for panel C were TE8808, TE8815, and TE8852-TE8860. Strains for panel D were TE8808, TE8815, and TE9236TE9247.
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The results of these experiments are shown in Fig 9. The effects observed for mutations in S. enterica
are broadly, but not completely, compatible with what was reported previously in E. coli. For three
positions of stem II lying within the antisense element and the corresponding three positions in the RBS
region, each mutation tested showed a mutant phenotype, with elevated rpoS expression (Fig 9, panel C).
Two differences from E. coli were noted. First, the magnitude of the effect on expression in the mutants
was somewhat lower in S. enterica than in E. coli. Second, the effect of compensatory mutations was not
as complete or dramatic as observed in E. coli. (Compare panel C with panel B).
A comprehensive set of mutations in the top strand of stem III was also constructed (Fig 9, panel D).
The pattern for this set is complex: of 12 mutations, three have a strong mutant phenotype with elevated
expression, three are weakly mutant with elevated expression, three are mutant but show decreased
expression (as much as 10-fold decreased), while three are wild type (Fig 9, panel D). We do not
currently have an explanation for this complex pattern. However, we emphasize that precisely the same
pattern was observed in a similar panel of mutations affecting E. coli rpoS at positions 461-464 (Cunning
and Elliott, unpublished data). The sole exception was G461A, which is mutant in E. coli and normal in
S. enterica.
The conservation of all nucleotides involved in the folded structure, as well as the phenotypes of
single mutations affecting paired nucleotides, are both consistent with a similar function for the antisense
element in S. enterica as in E. coli. As a final support for this interpretation, we sought and obtained
additional mutations, including some that have a down phenotype - decreased expression of rpoS. These
include a double mutation in stem I (C476G C477G, 7-fold elevated) and T468C (4-fold down).
Phenotypes for both of these mutants are consistent with the model.
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Discussion
Working with S. enterica, we examined the roles of DsrA and RprA regulatory RNAs in rpoS
expression under three specific conditions: growth at low temperature, after osmotic shock, and with
constitutive activation of the Rcs phosphorelay by an RcsC* mutation. Only osmotic shock revealed a
significant requirement for the two RNAs. The competence of S. enterica DsrA for rpoS regulation was
tested in an E. coli host and found nearly to be as effective as E. coli DsrA. Conservation of the ability to
stimulate RpoS expression is not surprising given the high sequence identity of the sRNAs and their
targets within the antisense element. The reciprocal test, of E. coli DsrA in an S. enterica host, showed no
stimulation of RpoS, but was inconclusive since Northern blots did not show any accumulation of the
small RNA. A variety of mutations affecting the antisense element of S. enterica rpoS and its RBS are
consistent with results seen with E. coli, except that the phenotype of predicted compensatory double
mutants was not clearly wild type. The reason for this difference from E. coli is not known. In summary,
sRNA regulation of rpoS is not conserved in S. enterica, despite sequence conservation of the sRNA
regulators and their target. The most likely explanation for this is RNA instability, though this was not
demonstrated directly.
How can the apparent non-conservation of DsrA and RprA function with respect to RpoS regulation
be reconciled with clear sequence conservation of the dsrA and rprA genes between E. coli, S. enterica
and other enterics? One idea would be that S. enterica uses other, or additional, sRNAs to regulate rpoS
translation. A role for sRNAs in mediating regulation of rpoS in S. enterica is suggested by the following
lines of evidence: (i) E. coli and S. enterica share a common pattern of rpoS translational regulation by
the antisense element (results), (ii) translation of rpoS depends on Hfq (44, 6), and (iii) many trans-acting
sRNA regulators require Hfq for activity (28).
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In addition to DsrA and RprA, other potential sRNA regulators of rpoS have been identified in E. coli
(46), although the relevant physiological conditions under which they regulate have not yet been
determined. It is not clear whether these are conserved in S. enterica, and to our knowledge a search for
unique sRNAs in S. enterica has not been done. This presents the possibility that sRNA regulators, in
addition to DsrA and RprA and having a synergistic or antagonistic role in regulating rpoS translation in
E. coli, are not conserved in S. enterica. The goal of this study was to determine the rpoS-specific effects
of these sRNAs, but it cannot be ruled out that perhaps DsrA and RprA regulate other targets in S.
enterica. In E. coli, multicopy dsrA has been shown to negatively regulate hns translation (42) and has a
modest effect on acid resistance (25). However, lack of sRNA accumulation is the simplest explanation
although the mechanism for this is unknown. In summary, although the sequences of these sRNAs are
conserved between E. coli and S. enterica, their function is not conserved.
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Table 2. Bacterial Strains.

S. enterica
TE6134

hfq-1::Mud-Cam

(Brown 96)

TE6153

r
putPA1303::Kan -katE-lac [op]

(Brown 96)

TE6266

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr]

(Brown 97)

TE6369-2

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (C470G)

(Brown 97)

TE6369-3

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (G550C)

(Brown 97)

TE6382

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (C470G) (G550C)

(Brown 97)

TE6557

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (C469G)

TE6558

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (G551C)

TE6590

r
hfq-1::Mud-Cam putPA1303:: Kan -rpoS-lac [pr] (C469G) (G551C)

TE6850

clpX1::Tn10d-Cam

(Cunning 99)

TE6851

mviA22::Tn10d-Cam

(Cunning 99)

TE8007

JF3490 dksA4::Tn10d-Tet

(J. Foster)

TE8012

TE8007 LT2A putPA1303::Kanr-katE-lac [op]

TE8544

putPA::katE-lac [op] rpoS1074::tetAR (A.S., deletes nt 461-464 of
rpoS leader)

49

TE8546

putPA::katE-lac [op] rpoS1076::cat (deletes from 110 bp upstream
to 469 of rpoS leader)

TE8566

putPA::katE-lac [op] ΔdsrA::tetAR

TE8567

putPA::katE-lac [op] ΔrprA::tetAR

TE8587

putPA::katE-lac [op] ΔdsrA::cat

TE8588

putPA::katE-lac [op] ΔcysC::tetAR

TE8589

putPA::katE-lac [op] rpoS1084::tetAR (AGGA, deletes nt 554-557
of rpoS leader)

TE8607

ΔcysC::tetAR

TE8608

r
putPA1303::Kan -katE-lac [op] ∆dsrA::cam

TE8610

r
putPA1303::Kan -katE-lac [op] ∆rprA::tetAR

TE8613

r
putPA1303::Kan -katE-lac [op] ∆dsrA::cam ∆rprA::tetAR

TE8622

ΔcysC::tetAR rpoS1076::cat (deletes from 110 bp upstream to 469
of rpoS leader)

TE8701

putPA::katE-lac [op] rpoS1080::tetAR (ΔA.S.-AGGA, deletes nt 461557)

TE8737

rpoS1082::MudJ (codon 66)
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TE8794

rpoS1083::MudJ (codon 222)

TE8804

nlpD::MudJ (nlpD codon 213, nt 9 of rpoS leader)

TE8805

rpoS1079::MudK (codon 187)

TE8807

rpoS1077::MudK (codon 22)

TE8808

rpoS1078::MudK (codon 216)

TE8810

rpoS1081::MudK (codon 250)

TE8815

rpoS1078::MudK (codon 216) hfq-1::Mud-Cam

TE8852

TE8815 rpoS (C469G)

TE8853

TE8815 rpoS (C470G)

TE8854

TE8815 rpoS (G471C)

TE8855

TE8815 rpoS (C549G)

TE8856

TE8815 rpoS (G550C)

TE8857

TE8815 rpoS (G551C)

TE8858

TE8815 rpoS (C469G) (G551C)

TE8859

TE8815 rpoS (C470G) (G550C)

TE8860

TE8815 rpoS (G471C) (C549G)

51

TE8935

nlpD::MudJ (nlpD codon 302, nt 276 of rpoS leader)

TE8936

rpoS:::MudJ (codon 36)

TE8983

rpoS1077::MudK (codon 22) ΔdsrA::cat

TE9049
TE9050

R
nlpD::[FRT-lacZY pKG137 Kan ] (nlpD codon 302, nt 276 of rpoS
leader)
R
rpoS::[FRT-lacZY pKG137 Kan ] (rpoS codon 36)

TE9051

R
rpoS::[FRT-lacZY pKG137 Kan ] (rpoS codon 222)

TE9052
TE9053

R
nlpD::[FRT-lacZY pKG137 Kan ] (nlpD codon 213, nt 9 of rpoS
leader)
R
rpoS::[FRT-lacZY pKG137 Kan ] (rpoS codon 4)

TE9160

rpoS1081::MudK (codon 250) (TTG -> ATG start codon)

TE9179

+
MS1868 StrA1 rpoS::[tetAR rpsL ] (AGGA)

TE9213

rpoS1081::MudK (codon 250) (TTG -> ATG start codon) ΔdsrA::cat

TE9219

rpoS1081::MudK (codon 250) (TTG -> ATG start codon) ΔdsrA::cat
ΔrprA::tetAR

TE9236

TE8815 rpoS (G461C)

TE9237

TE8815 rpoS (G461A)

TE9238

TE8815 rpoS (G461T)

TE9239

TE8815 rpoS (G462C)
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(S. Maloy)

TE9240

TE8815 rpoS (G462A)

TE9241

TE8815 rpoS (G462T)

TE9242

TE8815 rpoS (G463C)

TE9243

TE8815 rpoS (G463A)

TE9244

TE8815 rpoS (G463T)

TE9245

TE8815 rpoS (G464C)

TE9246

TE8815 rpoS (G464A)

TE9247

TE8815 rpoS (G464T)

TE9316

rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC55 (T903A)

TE9317

rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC

TE9318

rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC64 (F473I)

TE9333

gmm-21::MudJ zef-6829::tetAR rcsC55 (T903A)

TE9334

gmm-21::MudJ zef-6829::tetAR rcsC+

TE9352

rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC55 (T903A)
∆rprA::cam

TE9353

+
rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC ∆rprA::cam

TE9354

rpoS1077::MudK (codon 22) zef-6829::tetAR rcsC64 (F473I)
∆rprA::cam
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+

TE9368

gmm-21::MudJ zef-6829::tetAR rcsC64 (F473I)

TE9394

+
gmm-21::MudJ zef-6829::tetAR rcsC ∆rprA::cam

TE9395

gmm-21::MudJ zef-6829::tetAR rcsC55 (T903A) ∆rprA::cam

TE9396

gmm-21::MudJ zef-6829::tetAR rcsC64 (F473I) ∆rprA::cam

TE9427

TE8983 / pNM12 (vector)

TE9428

+
TE8983 / pNM3 (PBAD-E. coli dsrA )

TE9430

TE8983 / pBAD18 (vector)

TE9431

+
TE8983 / pTE780 (PBAD-S. enterica dsrA )

TE9452

TE8815 rpoS (T468C)

TE9453

TE8815 rpoS (C476A) (C477A)

E. coli
Q

SG22182

MC4100 ara mal::lacI

DDS1365

Q
MC4100 ara mal::lacI dsrA1::cat

TE6897

Q
r
MC4100 ara mal::lacI trpDC700:: putPA1303::Kan -katE-lac [op]

TE6898

Q
r
MC4100 ara mal::lacI trpDC700:: putPA1303::Kan -rpoS-lac [pr]

TE6913
TE6914
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Q
r
MC4100 ara mal::lacI trpDC700:: putPA1303::Kan -katE-lac [op]
dsrA1::cat
Q
r
MC4100 ara mal::lacI trpDC700:: putPA1303::Kan -rpoS-lac [pr]
dsrA1::cat

(D. Sledjeski)
(D. Sledjeski)

TE8096

+
BW26678 E. coli K-12 / pKD46 (AmpR, pSC101 rep(Ts) araC PBADλ red)

TE9062

+
zgd::tetAR (just upstream of rpsL )

TE9418

TE6914 / pBAD18 (vector)

TE9419

+
TE6914 / pTE780 (PBAD-S. enterica dsrA )

TE9424

TE6914 / pNM12 (vector)

D. Sledjeski

TE9425

+
TE6914 / pNM3 (PBAD-E. coli dsrA )

D. Sledjeski

(B. Wanner)

Numbering corresponds to the position of the last nucleotide retained from the rpoS leader or the codon
within which the fusion occurs (i.e. the last intact codon is one previous).
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Chapter 3: Literature review: Heme-mediated regulation of HemA
Heme
Porphyrins are a colorful group of organic compounds. Famous representatives include hemes and
chlorophylls, responsible for the red color of blood and the green pigment of plants, respectively. The
porphyrin nucleus is a highly conjugated ring, consisting of four pyrrole subunits interconnected via
methine bridges (Fig. 1). The double bonds joining the pyrrole rings are responsible for a characteristic
absorption peak around 400 nm, the Soret band, as well as a strong red fluorescence when viewed under
UV light. These properties are independent of the various groups attached to the periphery of the
macrocycle, which are used to classify different hemes (Fig, 10). The nitrogen atoms of the four pyrroles
are used to chelate divalent cations, including Fe

2+

for the formation of hemes, and Mg

2+

for chlorophylls

(reviewed in 7, 9).

Figure 10. The porphyrin nucleus is responsible for color. Protoporphyrin IX serves as substrate for synthesis of heme b
and chlorophylls. Groups attached to the periphery are methyl (M), propionate (P), and vinyl (V).
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Diverse biological roles for heme
Heme is an essential molecule for most archaea, bacteria, and eukaryotes. As the prosthetic group of
proteins, heme exhibits a wide variety of functions including electron transfer reactions, oxygen transport
and storage, and the reduction of oxygen to peroxides (reviewed in 4,11). Heme also functions as a
regulatory molecule by transient association with transcription factors and other proteins, modulating
levels of transcription, translation, and protein targeting (reviewed in 20). A combination of factors is
responsible for the diversity of heme function including the protein environment and the ligation state of
the iron atom (4).

Conservation of the heme pathway and the need for regulation
Heme-producing organisms synthesize tetrapyrroles from 5-aminolevulinic acid (ALA), the universal
precursor (reviewed in 2). Steps common in the synthesis of all tetrapyrroles constitute a linear series of
reactions that begins with the substrate ALA and ends with production of uroporphyrinogen III (Fig. 11).
This part of the pathway is highly conserved; the biosynthetic intermediates and enzyme-catalyzed
reactions are very similar or identical in all organisms (2, 9). Synthesis halts at uroporphyrinogen III for
those organisms that do not possess the necessary enzymes for synthesis of more complex tetrapyrroles
(20).

63

Figure 11. The heme biosynthesis pathway beginning with 5-aminolevulinic acid (ALA), the universal precursor.
Uroporphyrinogen III is the first branch point in the pathway, serving as substrate for heme synthesis as well as
corrinoids. Protoporphyrin IX is the direct precursor of heme b, from which other heme types are derived, and is also a
substrate for chlorophyll production.

Uroporphyrinogen III is the last common intermediate in the formation of all tetrapyrroles. The heme
biosynthetic pathway has multiple branches and various end products (Fig. 11), which suggests regulation
is required for the timely synthesis of appropriate products. Product levels also require strict regulation
since the accumulation of pathway intermediates, including porphyrins and iron, is toxic to cells due to
generation of highly reactive oxygen species in the presence of light (18, 30, 31). In humans,
dysregulation of heme biosynthesis presents as porphyria, one of a group of inherited or acquired
disorders that often includes photosensitivity of the skin and, in rare cases, neurological symptoms
(reviewed in 23).
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Two routes of ALA formation
Two independent routes exist for the formation of ALA, the universal precursor of heme biosynthesis.
The C4, or Shemin, pathway was the first to be discovered and its use is restricted to non-plant
eukaryotes, including humans and other animals, as well as the α-proteobacteria. ALA is formed from
the condensation of glycine with succinyl-coenzyme A (CoA) in a reaction catalyzed by ALA synthase
(ALAS). ALAS belongs to a catalytically versatile class of enzymes that require pyridoxal 5′phosphate (PLP) as a cofactor (6).
The C5 route is present in plants, algae, and most bacteria including the enteric bacteria (reviewed in
2). In this route, ALA is formed from the intact five-carbon skeleton of glutamate in several steps (Fig.
12). First, in a reaction identical to that in protein synthesis, glutamate is activated by ligation to tRNA in
the presence of Mg

2+

Glu

and ATP. Next, glutamyl tRNA reductase (HemA) reduces the glutamyl-tRNA

to an unstable intermediate, glutamate-1-semialdehyde (GSA) in a reaction that requires NADPH.
Finally, GSA aminotransferase (HemL) rearranges GSA to form ALA.

Figure 12. The C5 route of ALA production. The first reaction, catalyzed by Glutamyl-tRNA synthetase, is common to
protein synthesis and heme biosynthesis, therefore the reaction catalyzed by glutamyl-tRNA reductase (GTR, HemA) is
the first committed step in heme biosynthesis. In the absence of NADPH the esterase activity of GTR releases glutamate.
ALA is formed at a low rate in the absence of GSAM (HemL).
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The C5 pathway as a target for antimicrobials
The enzymes and reactions following ALA formation are largely conserved among heme-producing
organisms, therefore the enzymes of the C5 pathway, used by enteric and other pathogenic bacteria,
provide an attractive target for development of antimicrobials (7, 9). The viability of this endeavor is
supported by reduced infection capability of Salmonella hemA mutants (3).

Formation of ALA is the rate-limiting step of heme biosynthesis in eukaryotes
Mammals possess two ALAS isozymes, ALAS1 and ALAS2, which are regulated by heme via direct
and indirect mechanisms (reviewed in 1, 8). ALAS2 is expressed only in erythroid cells and provides the
heme for hemoglobin. ALAS1 is expressed in all tissues and satisfies the basal heme requirement. While
heme regulates the cellular expression and localization of both isozymes, it does so via different
mechanisms. The regulation of ALAS2 by heme is somewhat indirect, and results from a coordination of
iron levels and the end product of the pathway, heme, such that ALAS2 is synthesized only when iron is
available for insertion into protoporphyrin. In contrast, ALAS1 is directly feedback-regulated by heme,
inhibiting at the levels of transcription, translation, and mitochondrial import. Accumulation of pathway
intermediates in cells receiving exogenous ALA identifies ALAS as the rate-limiting step in all tissues.

HemA is regulated by heme availability
Several lines of evidence suggest that HemA serves as the critical control point in regulation of heme
biosynthesis. E. coli cells grown in the presence of ALA accumulate heme, indicating ALA formation is
rate-limiting for heme biosynthesis (21). Strains carrying cloned hemA genes of various species excrete
ALA and have a fluorescent red phenotype due to tetrapyrrole overproduction, whereas strains
overproducing HemB or HemL do not have a red fluorescent phenotype (5, 33, Choi and Elliott
unpublished results). These observations suggest that additional HemA enzyme increases flow through
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the heme biosynthetic pathway, whereas increased levels of HemB and HemL do not (Choi and Elliott
unpublished results). Furthermore, overexpression of hemA results in the accumulation of porphyrins and
ALA, suggesting HemA catalyzes the rate-controlling step in heme synthesis (5, 10). Strains mutant for
hemH (encoding ferrochelatase) accumulate protoporphyrin IX and exhibit light-sensitivity (18).
Ferrochelatase is the final enzyme in the heme pathway, forming heme by insertion of Fe

2+

into

protoporphyrin. The continued production of protoporphyrin in the absence of a functional ferrochelatase
enzyme suggests that the pathway’s end product, heme, is required to reduce flow through the pathway.
Mutations in hemA and hemL cause ALA auxotrophy. Whereas hemA mutants exhibit a strict
requirement for ALA supplementation, hemL mutants are leaky and can be adapted to growth in the
absence of ALA (33). Mutations in hemD or the enzymes of subsequent steps in the pathway result in the
accumulation of tetrapyrroles, which can be visualized as red fluorescence when colonies are viewed in
UV light. The intensity of fluorescence increases as cells become starved for heme (33). Collectively,
these observations provide compelling, but indirect, evidence that heme biosynthesis is regulated in
response to heme availability and that regulation converges at the rate-limiting enzyme, HemA.

Direct evidence for heme-mediated regulation of HemA
Experimentally, heme limitation can be imposed by adaptation of a bradytrophic hemL deletion
mutant to growth in the absence of ALA or starvation of mutants blocked at various steps of the heme
biosynthesis pathway after ALA formation (33). Glutamyl-tRNA reductase (GTR) activity in S. enterica
extracts from starved hemB, hemE, and hemH mutants is 15- to 25-fold greater than wild type. Similar
increases in HemA activity were measured in extracts from ALA-adapted hemL mutants. The increased
HemA activity correlates with an increase in HemA protein levels in starved cultures as determined by
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Western blot. In E. coli, Western blot analysis revealed similar increases in HemA levels in response to
heme-limitation suggesting regulation is conserved between S. enterica and E. coli (33).

Figure 13. The heme biosynthesis pathway and genes encoding the enzymes (shaded in gray). Mutant phenotypes are
discussed in the text.
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Conditional stability of HemA in response to heme
In S. enterica, a minimal (< 2-fold) increase in the activity of a hemA-lac transcriptional fusion was
observed concomitant with the increase in HemA enzyme and protein levels, demonstrating that
regulation is primarily post-transcriptional (33). The synthesis and turnover of HemA was assessed in an
S. enterica hemL mutant that had been either adapted (heme-limited) or supplemented with ALA and
therefore not limited for heme. Pulse-chase and co-immunoprecipitation revealed a slight increase (≈2fold) in protein synthesis in response to heme-limitation that could not account for the ≈20-fold increase
in activity (33, 35). The half-life of HemA in an S. enterica hemL mutant strain is 10-fold greater in
adapted (heme-limited) cultures compared to unrestricted cultures supplemented with ALA. HemA is
therefore primarily regulated by conditional stability, becoming more stable in response to heme
limitation (35).
Identification of a potential degradation signal in the HemA N-terminus
Analysis of HemA stability was extended to include an assessment of HemA-LacZ hybrid proteins,
containing amino acids 1-416 (HemA1–416- LacZ) or 1-18 (HemA1–18-LacZ). The stability of HemA1–
416-LacZ

mirrors that of native HemA. In contrast, HemA1–18-LacZ is unstable; however, its short half-

life is not conditional on heme limitation. HemA is degraded by the proteases Lon and ClpAP and
turnover of both hybrid proteins was blocked in a lon clpP double mutant of E. coli (35). The same
proteases are required for turnover of both HemA-LacZ fusion proteins and native HemA, suggesting that
the N-terminal 18 amino acids, or a subset of them, may constitute a degradation tag, which confers
sensitivity to proteolysis. However, the element that confers responsiveness to heme limitation requires
sequences further downstream. Further probing of the HemA N-terminus revealed that a mutant HemA
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construct, HemA[KK], containing two added lysine residues between positions 2 and 3, is stable when
expressed from the S. enterica chromosome and is also defective in heme-mediated regulation (34).

HemA: properties of the purified protein
HemA has been purified from several sources (Table 1 and references). Purified HemA from some
sources contains bound heme. The in vitro catalytic activity of some HemA enzymes is inhibited by
exogenous heme, although in some cases inhibition occurs only when cell extract is added to the reaction.
A correlation between the heme content of the purified enzyme and catalytic activity has been
demonstrated only for Chlorobium vibrioforme, with greater sensitivity to heme inhibition exhibited by
enzymes with lower heme content (29). The mechanism by which heme inhibits HemA enzyme activity
is unknown. The conditional inhibition exhibited by several enzymes suggests the mechanism varies with
the organism.
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Table 2. Heme content of purified HemA and heme inhibition of catalytic activity.

Heme
Domain

Organism

Bound

Bacteria

Escherichia coli

γ−proteobacteria

No

Salmonella enterica

γ−proteobacteria

Yes

Bacillus subtilis

Inhibition
of enzyme
activity
No

Reference

25,26
Unpublished
results

No

Acidothiobacillus
ferrooxidans

Acidophilic
γ−proteobacteria

-

Yes

13

Chlorobium
vibrioforme

Green sulfur bacterium

Yes

Yesb

29

Synechocystis sp.
PCC6803

Cyanobacterium

No

Yes

23

Archaea

Methanopyrus
kandleri

Thermophilic archaeon

No

Yes

16

Eukaryota

Chlamydomonas
reinhardtii

Unicellular green algae

Yes

Yesa.

28

Hordeum vulgare
(Barley)

Plant

Yes

Yes

22,32

a requires cell extract
b inhibition requires lowered heme content of purified enzyme

Catalytic mechanism of glutamyl-tRNA reductase
The crystal structure has been solved for HemA from Methanopyrus kandleri, a thermophilic
archaeon (16). An N-terminal catalytic domain contains an essential conserved cysteine residue (C50 in
71

S. enterica), a second domain binds NADPH, and the C-terminus is implicated in dimer formation (14,
19). The dimer forms an extended V-shaped cleft that can accommodate docking of GSA
aminotransferase. Formation of this complex would allow direct channeling of the unstable GSA
substrate from HemA to HemL (14).
The catalytic cysteine residue, C48 in M. kandleri, is completely conserved and mutation of this
residue results in an inactive enzyme (25, 27). The reactive thiol group of C48 acts as a nucleophile and
attacks the α-carbonyl group of tRNA-bound glutamate, forming an enzyme-localized thioester with
concomitant release of tRNA. Direct hydride transfer from NADPH leads to GSA formation (17). In the
absence of NADPH the esterase activity of GTR hydrolyzes the thioester releasing glutamate (15, 17).

A HemA C170A mutant in S. enterica is stable
In addition to the catalytic C48 (C50 in S. enterica and E. coli), HemA has additional non-conserved
cysteines. Of the characterized HemA proteins, only S. enterica and E. coli contain a cysteine at position
170. Purified, nearly wild type S. enterica HemA contains heme, which is non-convalently attached. In
S. enterica, mutation of C170 to alanine results in a purified protein lacking bound heme and which
exhibits increased stability in vivo, suggesting heme binding acts as a proteolytic tag for HemA (12).

Discussion
HemA of S. enterica is regulated by conditional stability, becoming more stable when heme is
limiting and subject to rapid turnover under non-limiting conditions (33, 35). Although the first 18 amino
acids of HemA are sufficient for degradation by Lon and ClpAP, other regions of the protein are required
for correct regulation in response to heme (35). The discovery of a mutant, C170A, that lacks bound
heme and is stable in vivo, suggests that heme binding to HemA targets the enzyme for proteolysis (12).
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Most HemA proteins have been characterized by analysis of in vitro enzyme activity. Little is known
about in vivo regulation for organisms other than S. enterica. In vitro analysis of the wild type and
C170A mutant proteins and their sensitivity to heme inhibition would help clarify the role of heme in
regulating S. enterica HemA. It is tempting to speculate that heme inhibition of the wild type protein
would demonstrate a requirement for additional factors, such as proteases, whereas the C170A mutant
retains insensitivity.
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Abstract
In Salmonella enterica serovar Typhimurium and Escherichia coli, as well as many other bacteria, the
hemA gene encodes the enzyme glutamyl-tRNA reductase (HemA, GluTR), which catalyzes the first
committed step in heme biosynthesis. Regulation of the heme pathway in these bacteria occurs by
stabilization of HemA protein in response to limitation for heme. Several groups including our own have
reported difficulties in overexpressing native HemA protein. We found that by removing as few as six
residues from the C-terminus, HemA can be expressed at high levels, and this form of the protein is still
regulated normally. The purified, truncated but otherwise wild type protein was found to contain bound
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heme, identified as heme b from the spectrum. Heme is released from the protein by treatment with thiol
reagents. Additionally, mutation of a single cysteine residue (C170) results in a protein that is both more
abundant and more stable than wild type when expressed from the chromosome in single copy, indicating
that C170 is required for normal regulation. When the mutant C170A protein was purified, it was found
not to contain detectable heme. These results suggest a model in which heme association with the
enzyme targets it for degradation in vivo.

Introduction
Glutamyl-tRNA reductase (HemA) catalyzes the first committed step of the heme biosynthetic
pathway. The substrate of this reaction is charged glutamyl-tRNAGlu, identical to the form used for
protein synthesis, which is first cleaved from the tRNA and then reduced using NADPH to form
glutamate-1-semialdehyde (GSA). The unstable semialdehyde is subsequently converted to 5aminolevulinic acid (ALA) by GSA aminotransferase, the product of the hemL gene (reviewed in
references 1 and 8). The latter reaction can also proceed slowly in vitro in the absence of an enzyme
catalyst (7).
HemA has been shown to be the target of heme-specific regulation in S. typhimurium and E. coli.
Previously, our laboratory described regulation of the HemA enzyme by a mechanism that involves
stabilization of the protein in response to heme limitation (26, 27). Experimentally, heme limitation can
be imposed by adaptation of a bradytrophic hemL deletion mutant to growth in the absence of ALA. The
growth rate of adapted hemL cells is approximately 80% of that of ALA-supplemented hemL or wild-type
cells. It is not yet clear how bacteria experience heme limitation in nature, but some possibilities include
the secretion of heme pathway inhibitors by competitor species, limitation for iron, or recovery from
nongrowing states.
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HemA is regulated by conditional stability, becoming more stable and thus more abundant under
heme-limiting conditions. In cells that are unrestricted for heme, HemA is subject to rapid turnover by
the proteases Lon and ClpAP (25). One striking observation was that just the N-terminal 18 amino acids
of HemA are sufficient for degradation by the same two proteases, as demonstrated in the context of a
HemA1-18-LacZ protein fusion. This construct was as stable as the nearly full-length HemA1-416-LacZ in a
lon clpP double mutant. However, the HemA1-18-LacZ hybrid protein was not correctly regulated by
heme (26). Clearly, although a key determinant of HemA proteolysis resides within the first 18 amino
acids of HemA, other regions of the protein are also involved in stabilization in response to heme
limitation. In the same study, we reported that insertion of two lysine residues between the second and
third amino acids from the N-terminus resulted in complete stabilization and increased abundance of
HemA under all growth conditions tested (27). This mutant (referred to as HemA[KK]) has been used in
the current work as a positive control for stabilized HemA.
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Figure 14. Two models for regulation of HemA turnover by heme limitation (adapted from 27). Asterisks indicate a
putative protease recognition site located within the N-terminus of HemA. The models postulate that HemA exists in
alternative conformations and that the protease-sensitive conformation can be stabilized in response to either heme
availability or intracellular redox potential.

We previously suggested a model in which HemA exists in two alternative conformations, proteasesensitive or protease-resistant, and that when heme is not limiting HemA exists in the protease-sensitive
conformation, in which it is targeted for degradation and thereby flow through the heme biosynthetic
pathway is reduced (Fig. 14). We proposed two specific models for how this might work: in one, cellular
redox status would be reflected in formation of a disulfide bond involving one of three cysteine residues.
In the second model, heme would bind directly to the enzyme. At the time, there was evidence that heme
could be associated with the HemA protein of some species (24), and this has been extended more
recently (20, 21). Our results support the second model and extend the previous work, by showing that
the C170A mutant of HemA is stabilized and more abundant than the wild type protein. Furthermore, we
show that over-expressed and purified (nearly wild type) protein contains bound heme, whereas its
C170A derivative does not.

Materials and Methods
Bacterial strains. The strains used in this study are listed in Table 1; all S. typhimurium strains are
derived from LT2.
Growth of cultures. Cultures were grown in either Luria-Bertani medium (4), modified minimal
MOPS (morpholinepropanesulfonic acid) medium (3, 13) containing 0.2% glycerol as the carbon source,
or NCE medium with 0.2% glycerol as the carbon source (2). Plates were prepared with nutrient agar
(Difco) and 5 g of NaCl per liter or with NCE medium. ALA was used at 2 µM in minimal medium and
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at 150 µM in rich medium. Adaptation of hemL mutant strains to growth in the absence of ALA
supplementation has been described previously (25).

Plasmid construction. Techniques for plasmid construction followed standard methods (10).
Mutations and C-terminal truncations were made by PCR and verified by sequencing. Plasmids are listed
in Table 1. Primer sequences are available upon request.

Purification of expressed proteins. Cultures were grown overnight in LB containing ampicillin
(100 µg/ml) and chloramphenicol (20 µg/ml), diluted 1:10 into fresh medium, and incubated at 30°C for 2
hours prior to induction with IPTG at a final concentration of 1 mM. Following an additional 3 hours of
incubation, cells were harvested by centrifugation. The cell pellet was resuspended in 10 ml of lysis
buffer (20 mM Tris pH 8.0, 250 mM NaCl, 10 mM imidazole, and 1:100 dilution of Sigma protease
inhibitor cocktail) then passed through a French press 2-3 times. The extracts were then clarified by
centrifugation at 24,000 x g for 30 minutes. Supernatants were mixed with 2.5 ml nickel-nitrilotriacetic
acid (Ni-NTA) resin (Qiagen) on a rocker at 4°C for 1 hour. Ni-NTA was washed twice in batches using
the above buffer, but containing 5 mM imidazole (wash 1) and 15 mM imidazole (wash 2), then poured
into polypropylene columns. Protein was eluted from the column in 5 ml of elution buffer (0.5 M
imidazole). Purified protein preparations were de-salted using PD-10 columns (GE Healthcare).
Immunological detection of proteins. Detection of HemA protein by Western blot has been
described in detail previously (25). With the exception of Figure 16, the primary antibody was antiHemA (H23), a mouse monoclonal antibody of the γ1 isotype (25). The monoclonal anti-FLAG antibody
was purchased from Sigma and used according to the manufacturer’s protocol.
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Spectrophotometry. The UV-Visible spectra shown in Figure 17 were recorded using a DW-2000
UV-Visible spectrophotometer (SLM-Aminco) using the split beam mode, 9.0 nm slit width, and a scan
rate of 1.0 nm min-1. The spectra shown in Figure 20 were recorded using a Synergy HT Plate Reader
(BioTek) with absorption measured at 10 nm intervals from 300-650 nm. Cytochrome c (Sigma C7752)
or hemin (Sigma H2375) standards were included in each 96-well plate used for determination of purified
HemA spectra. Three different conditions were measured per plate; the first measured 100 µl of
undiluted protein, the second measured proteins diluted in 100 µl alkaline pyridine solution (oxidized),
and the third followed addition of a few grains of sodium dithionite then mixing (reduced). The plate was
read at least twice following sodium dithionite addition to ensure complete reduction.
Heme content. The heme content of purified HemA was determined by the pyridine
hemochromogen assay (6). Purified proteins were diluted 1:1 in alkaline pyridine solution (0.2 M NaOH,
4.2 M pyridine). A few grains of sodium dithionite were added as a reducing agent. The difference in
absorption at 556 nm and 536 nm of the reduced protein in alkaline pyridine solution was used to
calculate the heme concentration using

εmM556-A537 value of 23.4.
-1

-1

HemA and HemA1-412-His6 is 30,940 M cm

The predicted

εmM

280

for both

(14).

Heme binding assay. Purified HemA1-412-His6 (100 µl) was diluted 1:10 in lysis buffer (see above)
then the absorbance at 280 nm and 420 nm was recorded. The diluted protein was mixed with Ni-NTA
resin that had been equilibrated with buffer. The mixture was incubated at 4°C on a rocker for 1 hr, then
poured into a polypropylene column. The flow-through was collected upon loading as well as for each
subsequent wash and the A420 measured. The column was washed three times with 5 ml buffer followed
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by three washes with 6 M guanidine-HCl (1 ml ea), and finally eluted with buffer containing 0.5 M
imidazole. In addition to the A420, the A280 of the eluate was also measured to estimate recovered protein.

Detection of heme-catalyzed peroxidase activity. Proteins were diluted in duplicate into standard
protein sample buffer lacking DTT, and β-ME was added to one.

Samples containing β-ME were boiled

for 10 minutes prior to loading onto 8% SDS-PAGE gels. Duplicate gels were loaded with 20 µg of
purified protein and 0.5 µg cytochrome c. Following SDS-PAGE, one gel was stained for total protein
using Coomassie blue and proteins in the second gel were transferred to a PVDF membrane for
subsequent detection of peroxidase activity. After transfer, the membrane was rinsed with ~10 ml PBS
for 1 min. Peroxidase activity was detected by covering the membrane with 1 ml each of SuperSignal
West Pico (Pierce) reagents for 4-5 min, then exposing to film.
Transfer of C170A mutation to the chromosome. PCR was performed using the plasmid pTE762
as the template. Integration into the S. typhimurium chromosome was achieved via linear transformation
using a previously published protocol (27) and results verified by sequencing.
HemA stability. Cultures grown overnight in MOPS 0.2% glycerol at 37°C were diluted 1:50 into
the same pre-warmed medium and incubated at 37°C. Protein synthesis was inhibited by addition of
chloramphenicol (200 ug/ml) at OD600 = 0.40. Aliquots were taken at 0, 30, and 60 minutes following
inhibition and prepared for SDS-PAGE and immunoblot using anti-HemA antibody.

Results
Overexpression of HemA
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Initial attempts to over-express either native or His-tagged HemA protein using the standard T7
system were unsuccessful (unpublished data, but see below). Other groups, working with various
organisms, have also reported difficulties including low yield, enzyme instability, and aggregation (4, 15,
18, 23, 24). Pointing to a possible solution of these difficulties, we observed that constructs bearing a
sequenced amber mutant allele of hemA (Q369Am) did allow over-expression of the truncated protein, at
a high level similar to that observed for other proteins we have purified (e.g. HemL, RpoS). This
encouraged us to test whether relatively short C-terminal truncations could be overexpressed at high
levels as well.
The hemA gene from Salmonella typhimurium was inserted into a plasmid derived from pET3 (22)
under the control of a T7 promoter. Various constructs encoded either full-length HemA (amino acids 1418) or one of several small C-terminal truncations; all bearing a C-terminal His6 tag in addition. Protein
overexpression was induced by a standard protocol in E. coli BL21(DE3)/pLysS (22). Analysis of whole
cell lysates from induced cultures showed that while the full-length HemA construct could not be
significantly over-expressed, a truncated form of HemA lacking six amino acids from the C-terminus
gave a strong visible band by Coomassie stain (Fig. 15A), and was at least 20-fold more abundant than
the native protein when analyzed by Western blot (Fig. 15B).
For the truncated proteins, degradation products are apparent below the HemA band, but these were
not observed for the full-length protein. Truncated proteins are often more susceptible to degradation
than native forms. Although we have not determined the level at which over-expression of full-length
HemA fails, the absence of degradation products suggests that proteolytic attack is probably not
significant. Models for HemA interaction with the tRNA substrate have been proposed in which the
interaction involves the C-terminus of the protein (12). Titration of tRNAGlu is a possible mechanism
limiting over-expression.
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Figure 15. Truncated HemA can be overexpressed. E. coli BL21(DE3) carrying plasmids that express either full-length
(amino acids 1-418) or C-terminally truncated Salmonella serovar Typhimurium HemA bearing a C-terminal His6 tag
were grown in LB medium containing ampicillin (100 µg per ml) and chloramphenicol (20 µg per ml) and induced with
IPTG (1 mM) 2 hrs prior to harvesting cells. In both A and B, numbers correspond to the position of the final amino acid
of HemA encoded by that construct. (A) Coomassie-stained gel. Arrows indicate the position of HemA in the lanes
containing the truncated forms.

(B) Western blot of HemA.

HemA was detected using anti-HemA H23 primary

antibody. An asterisk (*) indicates a 1:10 dilution in sample buffer alone; whereas the other samples were diluted 1:100
with lysate from the uninduced vector control strain. Strains analyzed: TE7771, TE7772, TE7875, TE7876, and TE7877.

HemA is composed of three domains: an N-terminal catalytic domain, an NADPH-binding domain,
and an extended C-terminal region required for dimerization (12). Purified E. coli HemA lacking its
entire C-terminal dimerization domain was reported to retain less than 5% of the enzymatic activity of the
wild-type protein (9). Therefore it was important to verify that truncated HemA is both functional and
correctly regulated by heme. Strains mutant for hemA require ALA supplementation for growth.
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Plasmid-encoded truncated and tagged Salmonella serovar Typhimurium hemA complemented an E. coli
hemA mutant and restored growth in the absence of ALA. Correct regulation in response to heme was
tested by Western blot (Fig. 16). To eliminate the possibility that a partial defect in enzyme activity of
the truncated proteins could affect results of the test, an E. coli host that is wild type for hemA was used,
and the plasmid-encoded proteins were specifically detected by an additional C-terminal FLAG tag. The
truncated HemA proteins demonstrated correct regulation in response to heme.

Figure 16 Truncated and FLAG-tagged HemA is correctly regulated by heme. Salmonella serovar Typhimurium
HemA was expressed from plasmids pTE764 (hemAp lac o hemA FLAG His6) and its truncated derivatives in an E.
coli hemA+ hemL mutant host strain. Cultures were grown in MOPS minimal medium containing ampicillin (50
µg/ml), IPTG (35 µg/ml), and 0.2% glycerol as the carbon source in the presence of 10 µM ALA or else adapted to
growth in the absence of ALA. HemA levels were detected by Western blot using anti-FLAG antibody. A strain
with plasmid encoding HemA truncated at position 408 and lacking the FLAG tag (408-) was included as a negative
control. Strains analyzed: TE7910, TE7911, TE7927, and TE7937.

Purification and characterization of HemA1-412-His6
His-tagged C-terminally-truncated HemA was purified by Ni-NTA affinity chromatography. The
purified protein was red in color, suggesting the presence of bound heme. This was surprising since in
previous studies purified E. coli HemA (which is 94% identical to S. typhimurium HemA) did not contain
heme or indeed any prosthetic group (16, 17). We suggest this difference may be related to the methods
used for over-expression of the E. coli protein, one of which resulted in its sequestration in inclusion
bodies (17). Additionally, in an earlier report it was demonstrated that E. coli HemA was soluble when
overexpressed from the T7 promoter in conjunction with chaperone proteins, yet the purified protein
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lacked heme (16). The tight association of chaperones with the purified HemA obtained by this method
could potentially block a tagging system.

Purified HemA contains bound heme
The absorption spectrum of purified HemA protein (Fig. 17) contains features characteristic of heme,
including a prominent peak at 424 nm (the Soret band). Upon reduction with Na-dithionite the peak at
424 nm became sharper and shifted toward a longer wavelength (426 nm), and two other peaks appeared,
one at 530 nm and another at 560 nm. The spectrum of reduced heme (hemin), which was used as a
control, was very similar to that of the purified protein (data not shown).

Figure 17 Purified HemA1-412-His6 has a heme b type
spectrum. The absorption spectra of purified HemA1412-His6

recorded before (black line) and after (dark

gray line) dithionite addition. The difference spectra
(light gray) is also shown.

The heme concentration in the purified protein was determined by pyridine hemochromogen assay
(6). Three separate protein preparations averaged 0.055 mol heme per mol protein monomer. This ratio
is lower than the heme:peptide ratio reported for HemA in other organisms. Purified HemA from
Chlorobium vibrioforme contained 1 mol heme per mol polypeptide (21), whereas HemA from
Chlamydomonas reinhardtii contained ≤ 0.2 mol heme per mol protein subunit (20).
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HemA Cys→ Ala mutants

89

The HemA protein of S. typhimurium contains three cysteines, C50, C74, and C170, all conserved
in E. coli. Of these, only C50, which is essential for catalysis (11, 16), is conserved among all organisms.
The presence of cysteine residues suggested the possibility that redox status or disulfide bond formation
may be important in HemA regulation. Each of the three cysteines of HemA was individually changed to
alanine resulting in the mutants C50A, C74A, and C170A. These were expressed in E. coli from a
plasmid bearing the native hemA promoter, but controlled by the lac operator and repressor. Both C74A
and C170A were capable of complementing an E. coli hemA mutant when expressed at normal levels,
thereby demonstrating that they encode functional proteins. As expected, plasmids encoding the Q369

Figure 18 Western blot analysis of HemA Cys→Ala
mutants in stationary phase. An E. coli hemA mutant host
strain (TE5812) carrying plasmid pTE740 (hemAp lac o

amber mutant and C50A mutant proteins were
unable to complement in the same test.

hemA His6) or one of its truncated derivatives was grown
overnight in NCE containing 0.2% glycerol, ampicillin (50
µg/ml), and ALA (10 µM), then diluted 1:50 into the same
medium plus IPTG (35 µM). After 24 hrs of incubation,
samples were prepared for Western blot using anti-HemA
(H23) antibody.

Strains analyzed:

TE7764, TE7767,

TE8219, TE8220, TE7929, and TE7884.

In a previous report we observed that HemA protein is undetectable by Western blot in wild-type
cultures grown overnight whereas the HemA[KK] mutant is maintained at easily detectable levels (27).
As a first assessment of the regulatory phenotype of the HemA Cys mutants, HemA was analyzed by
Western blot of lysates prepared from overnight cultures (Fig. 18). HemA C170A was nearly as abundant
as HemA[KK], whereas HemA levels in the other mutants and wild-type were at or below the limit of
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detection, suggesting that of the three mutants, C170A alone displays a regulatory defect. To verify this,
the Cys mutants were assessed for correct regulation in response to heme by comparison of HemA levels
in adapted (-ALA) and supplemented (+ ALA) cultures (Fig. 19). In ALA-supplemented cultures, HemA
levels were greater in the C170A mutant compared to the wild-type strain and C74 mutant (Fig. 19A), and
slightly greater than HemA[KK] in a similar test (Fig. 19B). We conclude that HemA[C170A] is a heme
regulatory mutant.

Figure 19. HemA[C170A] is a regulatory mutant. HemA was expressed from plasmid pTE740 and its derivatives in an
E. coli host strain mutant for hemA and hemL. Cultures were grown as described in the legend to Fig. 16. (A) Western
blot of HemA levels in adapted (- ALA) and supplemented (+ ALA) cultures. (B) Western blot of HemA levels in cultures
supplemented with ALA including the HemA[KK] mutant as a control for stability. Strains analyzed: TE7823, TE7824,
TE7849, TE7850.

Purification and characterization of His-tagged HemA C170A
HemA[C170A]1-412-His6 was purified according to the same protocol used for HemA1-412-His6. The
C170A mutant protein was colorless, suggesting that it is does not contain bound heme. The absence of
heme in purified C170A protein is also demonstrated by its absorption spectrum, which lacks the peaks
characteristic of heme-containing proteins (Fig. 20).
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Figure 20.

Characteristic heme b peaks are

absent from the HemA[C170A] spectrum. The
spectra of purified HemA1-412-His6 (solid line)
and HemA[C170A]1-412-His6 (dashed line).

Testing heme-protein association
The lack of heme in purified C170A prompted us to investigate the nature of the association between
heme and wild-type HemA. The HemA spectrum is that of a b-type heme; this class of molecules is
attached non-covalently. To test whether heme can be dissociated from HemA, we attempted to remove it
from the purified protein using the strong denaturant, 6M guanidine-HCl. Purified HemA1-412-His6
protein samples were re-bound to Ni-NTA resin and poured into a column. Removal of heme from the
enzyme was followed by measuring the A420 of column eluates. Columns were washed three times with 6
M guanidine-HCl. A maximum of 7% of the heme was removed by this treatment, and in two trials failed
to remove any of the bound heme (data not shown). These results demonstrate a strong association
between heme and HemA. Despite the above results, which indicate very tight binding, thiol reagents,
which have been used to distinguish covalent heme-protein bonds, are incompatible with Ni-NTA.
Therefore, the nature of the association between heme and HemA was further examined by different
method.

Detection of heme-associated peroxidase activity
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The second method used for detection of heme-binding proteins (such as cytochrome c) takes
advantage of the heme-associated peroxidase activity, which can be measured by standard ECL reagents
(a Western blot without the antibody; 5). Furthermore, if attachment of heme to HemA is covalent then
the peroxidase activity should be detected at the appropriate molecular mass following SDS-PAGE. (In
the following results, purified HemA1-412-His6 is referred to as ‘wild-type’).

Figure 21. ECL detection of heme-associated peroxidase activity in purified HemA. Purified proteins (≈20 µg) and
cytochrome c (0.5 µg) were run on duplicate 8% SDS-PAGE gels; one was stained with Coomassie Blue (left panel) and
the other was processed for detection of heme-associated peroxidase activity (right panel) as described in the methods
section. Samples in the lanes marked “+” were prepared in sample buffer containing β-ME and boiled, while those
marked “-“ were unheated and prepared in buffer lacking β-ME. Lane M contains Precision Plus Protein Standards
(Bio-Rad), and the molecular masses (kDa) for several of its component proteins are given for reference.

Purified wild type and C170A mutant proteins were assessed for heme-associated peroxidase activity
and duplicate gels were stained for protein with Coomassie Blue (Fig. 21). Cytochrome c was included as
a positive control for covalent attachment of heme, and its heme-associated peroxidase activity was
detected at the molecular mass of the protein, ~13 kDa. The calculated molecular mass of monomeric
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HemA is approximately 46 kDa. Both the wild type and C170A proteins were detected in Coomassiestained gels at the predicted molecular mass (Fig. 21, left lanes), however peroxidase activity was
detected only for the wild-type protein and then only in unheated samples lacking both DTT and β-ME.
Any one of three treatments (DTT, β-ME, boiling) abolished the signal from HemA (Fig. 21, and data not
shown) indicating that heme is not covalently bound. No signal was observed for the C170A mutant
under any of the conditions tested. Three bands are observed for the untreated wild-type sample. The
smallest and most abundant band corresponds to HemA protein. The bands above it are probably
aggregates as observed in other studies (16, 18, 23).

Figure 22 HemA C170A is stable. Native and mutant
HemA proteins were expressed from the Salmonella
chromosome in single copy.

Cultures were grown in

MOPS minimal medium containing 0.2% glycerol to an
OD600 = 0.40. Protein synthesis was inhibited by addition
of chloramphenicol (200 µg/ml).

(A) Western blot of

HemA levels at 0, 30, and 60 minutes following inhibition
of protein synthesis. (B) Densitometry analysis (ImageJ).
HemA was unstable in the wild-type strain (closed circles)
and nearly stable over the time course for HemA[KK]
(closed squares) and HemA[C170A] (open circles).
Strains analyzed: TE6825, TE7700, and TE9287.

HemA stability by immunoblot
According to the models in Fig. 14, heme binding to HemA acts as a tag that leads to proteolytic
attack. The absence of bound heme in purified C170A led us to predict that the mutant would exhibit
increased stability over wild-type HemA. The stability of native and C170A mutant HemA, expressed in
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single copy from the Salmonella serovar Typhimurium chromosome, was analyzed by Western blot after
inhibition of protein synthesis (Fig. 22). HemA[KK], included as a positive control, remained stable over
the time course of the experiment. Wild-type HemA was present at lower levels than the mutants and was
detectable only at the initial time point. In support of the model, the C170A mutant was nearly as stable
as HemA[KK].

Discussion
In the present work we have shown that truncated HemA protein, lacking only six C-terminal amino
acids, is functional, exhibits correct regulation in response to heme availability, and can be efficiently
overexpressed and purified. A fraction of purified HemA1-412-His6 contained heme, which is noncovalently attached. In a previously posited model, we suggested that heme binding to HemA serves as a
tag for HemA proteolysis. In support of this model, we identified a mutation, C170A, which both
abrogates heme binding and increases protein stability.
HemA purified from Chlorobium vibrioform (21), Chlamydomonas reinhardtii (20), and barley (24)
contains heme, whereas the purified proteins from E. coli (16, 17) and Methanopyrus kandleri (11) do
not. Among these organisms, only S. typhimurium and E. coli possess a cysteine at position 170; a valine
occupies the equivalent position in the others. While we have shown that C170 is necessary for HemA to
bind heme in Salmonella serovar Typhimurium, it is not conserved among the organisms in which heme
is known to associate with HemA. This finding further supports a non-covalent association between
heme and HemA.
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Based on the crystal structure of HemA from Methanopyrus kandleri (12) and a structure-based
sequence alignment with E. coli HemA (16), C170 is located within the NADPH binding domain. The
C170A Salmonella mutant protein complemented an E. coli hemA mutant thereby demonstrating that the
enzyme is functional. This suggested that the mutation did not affect the enzyme’s ability to bind
NADPH, a hypothesis further supported by the work of Schauer and coworkers who reported that a
purified mutant HemA protein from E. coli, C170S, retained nearly wild-type reductase and esterase
activity (16). Because E. coli wild-type HemA lacks associated heme, which we suggested may be due to
the purification protocols employed (see text), mutation of C170 in E. coli has no reported phenotype.

Because such a small fraction of purified HemA1-412-His6 contained heme, we were unable to identify
the exact site of heme attachment, however C170 is clearly important in this capacity as shown by the
lack of bound heme in the purified C170A mutant protein. Due to the non-covalent association of heme
with HemA, as well as the lack of conservation of C170, it seems unlikely that this residue is directly
involved in heme binding. The simplest explanation is that mutation of C170 results in a structural
change that abrogates heme binding, possibly by disrupting the shape or chemistry of the heme pocket or
altering the region recognized by a tagging system.
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Table 3. Bacterial strains

Strain

Genotype

Salmonella
TE6285

LT2

TE7700

zde-1858::Tn10d-Tet hemA [KK]

TE9287

zde-1858::Tn10d-Tet hemA [C170A]

E. coli
TE5812

MC4100 hemA8

TE6160

MC4100 hemL::Kan (EcoRI)

TE7764

MC4100 hemA8/pTE740

TE7767

MC4100 hemA8/pTE741 [KK]

TE7771

BL21(DE3)/pLysS/pET3a

TE7772

BL21(DE3)/pLysS/pTE700

TE7806

hemA8 hemL::kan

TE7823

MC4100 hemA8 hemL::kan (EcoRI)/pTE740

TE7824

MC4100 hemA8 hemL::kan (EcoRI)/pTE741
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TE7849

MC4100 hemA8 hemL::kan (EcoRI)/pTE761

TE7850

MC4100 hemA8 hemL::kan (EcoRI)/pTE762

TE7875

BL21(DE3)/pLysS/pTE603

TE7876

BL21(DE3)/pLysS/pTE751

TE7877

BL21(DE3)/pLysS/pTE752

TE7884

MC4100 hemA8/pTE748

TE7910

MC4100 hemL::Kan (EcoRI)/pTE749

TE7911

MC4100 hemL::Kan (EcoRI)/pTE753

TE7927

MC4100 hemL::Kan (EcoRI)/pTE763

TE7929

MC4100 hemA8/pTE760

TE7937

MC4100 hemL::Kan (EcoRI)/pTE764

TE8219

MC4100 hemA8/pTE761

TE8220

MC4100 hemA8/pTE762

TE9510

BL21(DE3)/pLysS/pTE752

TE9511

BL21(DE3)/pLysS/pTE778
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Plasmids

pTE603

PT7 hemA Q369 Am-His6

pTE700

PT7 hemA1-418-His6

pTE740

hemAp lac o NdeI hemA prfA (codon 6)

pTE741

hemAp lac o NdeI hemA [KK] prfA (codon 6)

pTE749

hemAp lac o hemA RBS NdeI hemA (codon 408) XhoI His6 BamHI

pTE751

PT7 hemA1-408-His6

pTE752

PT7 hemA1-412-His6

pTE753

hemAp la co hemA RBS NdeI hemA codon 408 XhoI FLAG His6 BamHI

pTE761

hemAp la co NdeI hemA [C74A] prfA (codon 6)

pTE762

hemAp lac o NdeI hemA [C170A] prfA (codon 6)

pTE763

hemAp la co hemA RBS NdeI hemA1-412 XhoI FLAG His6 BamHI

pTE764

hemAp la co hemA RBS NdeI hemA1-418 XhoI FLAG His6 BamHI
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